data_6kow_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6kow _Structure_validation_residue.Date_analyzed 2019-08-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.461 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.663 ' H ' ' HG1' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 3' ' ' ILE . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 3.3 t30 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 26' ' ' VAL . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 29.1 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 60' ' ' ASN . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 57' ' ' SER . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 mp . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 21' ' ' ASP . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 19' ' ' PRO . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.562 HD22 ' HZ1' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.562 ' HZ1' HD22 ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 69.8 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.6 mp . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' CD1' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 3' ' ' ILE . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.49 ' HG1' ' H ' ' A' ' 9' ' ' THR . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 7' ' ' THR . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 23' ' ' ILE . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.541 HD22 ' CE ' ' A' ' 29' ' ' LYS . 21.6 t30 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.541 ' CE ' HD22 ' A' ' 25' ' ' ASN . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.285 0.564 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.62 ' CD1' ' HZ3' ' A' ' 33' ' ' LYS . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 30' ' ' ILE . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.2 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HZ3' ' CD1' ' A' ' 15' ' ' LEU . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 33.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.441 0.638 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' A' ' 7' ' ' THR . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' GLU . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.674 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.674 ' HZ2' HD22 ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.5 2.062 0 CA-C-O 121.425 0.631 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 3' ' ' ILE . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 35.1 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.355 0.598 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 39.1 t30 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 13.9 t-20 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.355 0.598 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' ASP . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' PRO . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 60' ' ' ASN . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.553 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' H ' ' HG1' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.229 0.537 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.46 ' H2 ' ' H ' ' A' ' 2' ' ' GLN . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.46 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 3' ' ' ILE . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 23' ' ' ILE . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.52 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 30' ' ' ILE . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt . . . . . 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.693 ' HG1' HD21 ' A' ' 25' ' ' ASN . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.693 HD21 ' HG1' ' A' ' 22' ' ' THR . 42.6 m-80 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 56' ' ' LEU . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 HD12 ' A' ' 23' ' ' ILE . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.635 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.635 ' H ' ' HG1' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' CB ' ' HE2' ' A' ' 68' ' ' HIS . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.42 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 66.2 t30 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' VAL . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 46' ' ' ALA . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 20' ' ' SER . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.244 0.545 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HE2' ' CB ' ' A' ' 6' ' ' LYS . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.481 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 3' ' ' ILE . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 68' ' ' HIS . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' ' HZ2' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HZ2' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.8 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.5 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.476 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 6' ' ' LYS . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.693 ' H2 ' ' H ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 3' ' ' ILE . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HZ2' ' NE2' ' A' ' 68' ' ' HIS . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.693 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.462 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.709 ' H ' ' HG1' ' A' ' 22' ' ' THR . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 30' ' ' ILE . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' ' HZ2' ' A' ' 6' ' ' LYS . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' GLU . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' ILE . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HZ3' ' CD1' ' A' ' 43' ' ' LEU . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.72 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.72 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.401 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' N ' ' CG2' ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 48.3 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' ASP . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' OD1' ' OD2' ' A' ' 21' ' ' ASP . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 6.6 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.311 0.577 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 3' ' ' ILE . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.482 ' H ' HD21 ' A' ' 25' ' ' ASN . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.482 HD21 ' H ' ' A' ' 22' ' ' THR . 83.7 m-20 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 57' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.461 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.663 ' H ' ' HG1' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm -60.48 150.41 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.55 -56.4 5.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 110.438 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 65' ' ' SEP . 66.8 mmtt -76.71 -30.59 56.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 0.0 110.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 50.41 9.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.582 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.529 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -86.26 124.66 32.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt -95.52 165.37 12.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -104.84 119.83 39.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.76 -173.38 52.51 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 3' ' ' ILE . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 3.3 t30 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 26' ' ' VAL . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 29.1 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 60' ' ' ASN . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 57' ' ' SER . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.56 118.51 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.06 48.99 0.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 110.1 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' SEP . 64.7 mttm -108.31 10.28 27.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.402 -0.811 . . . . 0.0 109.112 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 63.07 -70.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.631 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 7.8 mp -84.93 117.98 24.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 mp -99.8 150.35 22.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 46.87 55.01 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.55 -38.89 95.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 21' ' ' ASP . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 19' ' ' PRO . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.562 HD22 ' HZ1' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.562 ' HZ1' HD22 ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 69.8 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt -60.45 150.19 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -154.41 57.84 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' NZ ' ' CE2' ' A' ' 45' ' ' PHE . 30.1 mmtp -100.68 -16.32 17.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 54.24 67.74 0.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.521 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 9.6 mp -86.87 117.39 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.149 -0.969 . . . . 0.0 109.313 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' CD1' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt -116.15 139.45 50.31 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -86.49 139.03 31.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.2 9.54 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.521 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 3' ' ' ILE . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 ' HG1' ' H ' ' A' ' 9' ' ' THR . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 7' ' ' THR . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 23' ' ' ILE . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.541 HD22 ' CE ' ' A' ' 29' ' ' LYS . 21.6 t30 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.541 ' CE ' HD22 ' A' ' 25' ' ' ASN . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.64 150.08 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -71.43 -61.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -81.28 -30.8 33.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 65' ' ' SEP . 80.9 tt0 46.84 -112.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.407 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -88.35 117.78 27.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 125.42 51.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -60.34 134.51 57.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.07 -164.72 53.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.504 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.62 ' CD1' ' HZ3' ' A' ' 33' ' ' LYS . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 30' ' ' ILE . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.2 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.62 ' HZ3' ' CD1' ' A' ' 15' ' ' LEU . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 33.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.98 144.66 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.44 -59.18 2.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -73.7 -28.49 61.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.648 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 52.74 81.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -87.54 158.25 18.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.5 tp -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -67.96 -37.66 81.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.229 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.13 89.5 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.489 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' A' ' 7' ' ' THR . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' GLU . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.674 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.674 ' HZ2' HD22 ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.55 136.51 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.46 -53.51 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.023 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 64' ' ' GLU . 41.9 mmtm -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.932 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 pt-20 32.06 68.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.288 0.566 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.4 mt -114.64 117.54 31.14 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.476 -0.765 . . . . 0.0 109.682 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 74' ' ' ARG . 25.3 mt -84.64 165.51 17.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 73' ' ' LEU . 67.0 ttt180 59.56 151.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.626 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.22 161.09 34.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.529 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 3' ' ' ILE . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 35.1 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.419 HH12 ' CD ' ' A' ' 74' ' ' ARG . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.18 131.29 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -69.98 -50.72 38.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 64' ' ' GLU . 33.3 mtmm -65.7 -31.77 72.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.992 -1.067 . . . . 0.0 110.037 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 82.1 tt0 41.54 66.17 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -0.783 . . . . 0.0 110.258 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.6 122.92 41.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt -114.98 144.86 42.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' CD ' HH12 ' A' ' 42' ' ' ARG . 54.3 ttt85 -170.83 136.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.122 -0.986 . . . . 0.0 109.517 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.38 -176.0 47.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.509 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 39.1 t30 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 13.9 t-20 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.85 132.29 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 27.0 mp0 -60.38 -50.04 75.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.644 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 64' ' ' GLU . 63.3 mttp -64.61 -24.74 67.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.091 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' LYS . 19.6 pt-20 37.32 43.42 0.37 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.599 -0.688 . . . . 0.0 110.792 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.24 152.71 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 0.0 109.74 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 8.3 mp -93.19 134.15 35.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -59.6 -44.4 93.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.347 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.21 -1.5 0.05 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.558 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 21' ' ' ASP . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 19' ' ' PRO . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE1' ' NZ ' ' A' ' 63' ' ' LYS . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 60' ' ' ASN . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 pt -60.47 146.22 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.93 43.99 1.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.506 -0.746 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' SEP . 30.6 mmtp -103.13 -1.05 29.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.436 -0.79 . . . . 0.0 109.268 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 62.9 -70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 109.551 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.462 ' CG2' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.81 117.62 28.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' NE2' ' CG2' ' A' ' 66' ' ' TPO . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.41 166.02 11.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.21 -28.58 69.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.99 -173.88 46.55 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.991 -1.45 . . . . 0.0 109.586 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HZ2' ' CD1' ' A' ' 43' ' ' LEU . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 ' CD1' ' HZ2' ' A' ' 27' ' ' LYS . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' CB ' ' NZ ' ' A' ' 63' ' ' LYS . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.553 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' H ' ' HG1' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -85.35 150.3 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -153.09 75.24 1.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.416 -0.802 . . . . 0.0 109.086 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' NZ ' ' CB ' ' A' ' 46' ' ' ALA . 88.5 tttt -108.47 -30.3 8.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.718 . . . . 0.0 109.91 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -174.57 158.57 2.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -89.48 123.97 34.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 109.598 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt -89.76 143.76 26.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 49.34 -153.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.22 -161.3 31.96 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' H2 ' ' H ' ' A' ' 2' ' ' GLN . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 3' ' ' ILE . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 23' ' ' ILE . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.52 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 30' ' ' ILE . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -92.14 126.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -150.95 -48.88 0.12 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.013 -1.054 . . . . 0.0 109.71 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.03 -7.19 10.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -0.996 . . . . 0.0 109.38 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' SEP . 74.4 mm-40 -87.75 70.98 9.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -78.64 117.79 20.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt -112.37 140.23 47.27 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -159.49 146.45 16.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.94 3.71 90.5 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.536 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 18' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.693 ' HG1' HD21 ' A' ' 25' ' ' ASN . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.693 HD21 ' HG1' ' A' ' 22' ' ' THR . 42.6 m-80 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 56' ' ' LEU . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -59.68 139.33 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.94 -67.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.279 -0.888 . . . . 0.0 110.783 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' SEP . 69.0 mttm -80.48 -31.4 37.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.543 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.45 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 109.549 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.526 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -67.2 119.54 12.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -97.68 125.92 42.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 46.77 63.17 2.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 109.68 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.19 95.32 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.498 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 HD12 ' A' ' 23' ' ' ILE . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.65 HH11 HH22 ' A' ' 74' ' ' ARG . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.635 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.635 ' H ' ' HG1' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -72.59 150.38 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.81 70.25 1.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.563 ' NZ ' ' HE2' ' A' ' 68' ' ' HIS . 83.3 tttt -108.24 -29.74 8.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 65' ' ' SEP . 88.3 tt0 -172.32 153.99 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.418 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.48 119.82 31.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.563 ' HE2' ' NZ ' ' A' ' 63' ' ' LYS . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.02 160.5 14.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.65 HH22 HH11 ' A' ' 42' ' ' ARG . 66.1 ttt180 -152.37 122.2 6.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.336 -0.853 . . . . 0.0 109.271 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.77 101.86 0.25 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.565 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' CB ' ' HE2' ' A' ' 68' ' ' HIS . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.42 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 66.2 t30 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 26' ' ' VAL . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 26' ' ' VAL . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.525 HH11 ' C ' ' A' ' 75' ' ' GLY . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 46' ' ' ALA . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 20' ' ' SER . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 tp -67.17 150.31 11.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -88.16 -51.03 6.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.713 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 64' ' ' GLU . 61.8 tttp -65.42 -32.02 73.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.943 -1.098 . . . . 0.0 110.292 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 77.6 tt0 41.87 61.87 1.77 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.332 -0.855 . . . . 0.0 110.418 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.29 148.07 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' HE2' ' CB ' ' A' ' 6' ' ' LYS . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.481 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp -104.45 158.39 16.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LEU . 55.8 ttm-85 59.86 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' C ' HH11 ' A' ' 42' ' ' ARG . . . 159.49 53.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.615 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 3' ' ' ILE . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE1' ' O1P' ' A' ' 66' ' ' TPO . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 68' ' ' HIS . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CG2' ' HZ2' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HZ2' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.8 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.5 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' H ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.476 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.01 150.24 6.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.02 40.37 2.71 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.494 -0.754 . . . . 0.0 109.083 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -88.74 -26.31 21.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 0.0 109.239 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 52.7 46.37 26.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.44 ' O1P' ' CE1' ' A' ' 4' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.0 117.38 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 6' ' ' LYS . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -113.94 143.54 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -146.68 130.51 17.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.16 83.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.693 ' H2 ' ' H ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 3' ' ' ILE . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HZ2' ' NE2' ' A' ' 68' ' ' HIS . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.693 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.709 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.462 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.709 ' H ' ' HG1' ' A' ' 22' ' ' THR . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 30' ' ' ILE . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.24 150.28 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -143.78 76.65 1.52 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.355 -0.841 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -97.56 -3.34 39.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 98.5 mt-10 50.72 45.71 26.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.405 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt -93.78 117.09 29.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.572 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.438 ' NE2' ' HZ2' ' A' ' 6' ' ' LYS . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt -112.03 136.0 51.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 48.4 mtm180 -99.99 140.96 33.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.309 -0.869 . . . . 0.0 109.249 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.17 1.74 90.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' GLU . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' ILE . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HZ3' ' CD1' ' A' ' 43' ' ' LEU . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.72 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.72 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.401 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' N ' ' CG2' ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.485 ' CD1' ' H ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -84.94 116.81 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.83 -38.02 13.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.125 -0.984 . . . . 0.0 110.33 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' SEP . 63.6 mttp -69.69 -31.79 70.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.099 . . . . 0.0 110.221 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' H ' ' CD1' ' A' ' 61' ' ' ILE . 98.9 mt-10 43.26 19.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.419 -0.8 . . . . 0.0 110.125 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.07 139.99 35.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -113.0 141.92 46.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -71.96 -48.12 47.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.15 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.35 15.53 70.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.566 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 48.3 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 21' ' ' ASP . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' OD1' ' OD2' ' A' ' 21' ' ' ASP . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 6.6 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.424 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.61 119.4 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -89.34 65.33 7.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -80.6 -30.32 36.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 52.18 56.14 8.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.434 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.58 117.66 23.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 125.03 50.08 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.46 160.34 31.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.27 4.05 90.33 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 CA-C-O 117.929 -1.484 . . . . 0.0 109.536 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt -81.83 128.95 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.76 64.74 5.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.898 . . . . 0.0 109.198 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HZ3' ' H ' ' A' ' 68' ' ' HIS . 19.9 tptm -71.25 -30.35 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 52.85 36.16 20.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.158 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.503 ' OG ' ' N ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.503 ' N ' ' OG ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt -90.09 117.65 29.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.452 ' H ' ' HZ3' ' A' ' 63' ' ' LYS . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -85.89 126.15 33.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 51.66 -117.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.416 -0.803 . . . . 0.0 109.673 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.82 -168.29 50.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.522 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 3' ' ' ILE . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.482 ' H ' HD21 ' A' ' 25' ' ' ASN . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.482 HD21 ' H ' ' A' ' 22' ' ' THR . 83.7 m-20 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 74' ' ' ARG . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 57' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.98 134.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.12 -53.15 59.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' GLU . 68.6 mttm -64.64 -32.07 73.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.032 -1.042 . . . . 0.0 110.24 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 75.7 tt0 43.06 58.93 3.1 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TPO . . . . . 0.452 ' N ' ' CE ' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.01 158.09 4.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 74' ' ' ARG . 51.4 mt -81.23 125.65 30.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 40' ' ' GLN . 54.5 ttp180 57.37 162.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.434 -0.792 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.64 -173.93 44.5 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.601 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.583 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 29' ' ' LYS . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 20' ' ' SER . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 56' ' ' LEU . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 70' ' ' VAL . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 55' ' ' THR . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 24.9 t-20 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 70.8 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' C ' HD12 ' A' ' 69' ' ' LEU . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 9.1 mp . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.672 HD11 HH11 ' A' ' 72' ' ' ARG . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD2' HG11 ' A' ' 17' ' ' VAL . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.1 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.626 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.67 ' N ' HG22 ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 55' ' ' THR . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.6 mp . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.672 HH11 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.7 t-20 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 71' ' ' LEU . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 HE21 HD21 ' A' ' 71' ' ' LEU . 40.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.285 0.564 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 30' ' ' ILE . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 73' ' ' LEU . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' THR . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 51' ' ' GLU . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 75.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.433 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' THR . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 HD11 ' A' ' 67' ' ' LEU . 46.8 mt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.546 HD11 HD13 ' A' ' 61' ' ' ILE . 68.6 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.441 0.638 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.447 ' C ' HD12 ' A' ' 69' ' ' LEU . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 68' ' ' HIS . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.422 ' H ' HD11 ' A' ' 8' ' ' LEU . 48.5 tp . . . . . 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG2' HD13 ' A' ' 69' ' ' LEU . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 7' ' ' THR . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 13' ' ' ILE . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 21' ' ' ASP . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.834 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.834 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.61 ' N ' HG22 ' A' ' 55' ' ' THR . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 55' ' ' THR . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 56' ' ' LEU . 27.4 mt . . . . . 0 N--CA 1.5 2.062 0 CA-C-O 121.425 0.631 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 ' CG2' HD13 ' A' ' 69' ' ' LEU . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' HD12 ' A' ' 56' ' ' LEU . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 57.5 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.538 ' N ' HG22 ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.355 0.598 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 8' ' ' LEU . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG22 ' A' ' 7' ' ' THR . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 56' ' ' LEU . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 55' ' ' THR . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.6 t-20 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 44' ' ' ILE . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 56' ' ' LEU . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' N ' HG22 ' A' ' 55' ' ' THR . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.355 0.598 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' C ' HD12 ' A' ' 69' ' ' LEU . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' ILE . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 51' ' ' GLU . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' O ' HD12 ' A' ' 23' ' ' ILE . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.569 ' N ' HG22 ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 55' ' ' THR . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 67' ' ' LEU . 13.6 pt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 61' ' ' ILE . 28.4 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' C ' HD12 ' A' ' 69' ' ' LEU . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 69' ' ' LEU . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 70' ' ' VAL . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 14' ' ' THR . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' VAL . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 20' ' ' SER . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.229 0.537 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HD12 ' A' ' 69' ' ' LEU . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 7' ' ' THR . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 16' ' ' GLU . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.711 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.711 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt . . . . . 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 9' ' ' THR . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 17' ' ' VAL . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 16' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 57' ' ' SER . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 55' ' ' THR . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.56 ' C ' HD12 ' A' ' 69' ' ' LEU . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.3 mp . . . . . 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 21' ' ' ASP . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 17' ' ' VAL . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 17' ' ' VAL . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.502 ' C ' HD12 ' A' ' 69' ' ' LEU . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' THR . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.55 ' ND2' ' NZ ' ' A' ' 29' ' ' LYS . 3.5 t-20 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.55 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 23' ' ' ILE . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 55' ' ' THR . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.244 0.545 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.428 ' H ' ' HA ' ' A' ' 16' ' ' GLU . 52.0 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 55' ' ' THR . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.636 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 52.5 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.0 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG22 ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 70' ' ' VAL . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 73' ' ' LEU . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 55' ' ' THR . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 8' ' ' LEU . 50.8 mt . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 13' ' ' ILE . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' OD2' ' A' ' 21' ' ' ASP . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' GLY . 54.1 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.788 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.788 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' H ' HG22 ' A' ' 61' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.491 ' C ' HD12 ' A' ' 69' ' ' LEU . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 12.8 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.311 0.577 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 11' ' ' LYS . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' THR . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' A' ' 25' ' ' ASN . 5.2 m120 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 55' ' ' THR . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 ' HZ2' ' A' ' 33' ' ' LYS . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' THR . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 50' ' ' LEU . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 25' ' ' ASN . 6.1 m120 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 68' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' H ' HD23 ' A' ' 67' ' ' LEU . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.583 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 29' ' ' LYS . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 20' ' ' SER . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 56' ' ' LEU . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm -60.48 150.41 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.55 -56.4 5.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 110.438 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' C ' ' H ' ' A' ' 65' ' ' SEP . 66.8 mmtt -76.71 -30.59 56.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 0.0 110.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 50.41 9.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.582 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.736 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -86.26 124.66 32.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 70' ' ' VAL . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt -95.52 165.37 12.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -104.84 119.83 39.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.76 -173.38 52.51 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 55' ' ' THR . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 24.9 t-20 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 70.8 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.56 118.51 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.06 48.99 0.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 110.1 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 65' ' ' SEP . 64.7 mttm -108.31 10.28 27.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.402 -0.811 . . . . 0.0 109.112 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 63.07 -70.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.631 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.524 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.8 mp -84.93 117.98 24.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' C ' HD12 ' A' ' 69' ' ' LEU . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 9.1 mp -99.8 150.35 22.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 46.87 55.01 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.55 -38.89 95.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.672 HD11 HH11 ' A' ' 72' ' ' ARG . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD2' HG11 ' A' ' 17' ' ' VAL . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.1 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.626 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.67 ' N ' HG22 ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 55' ' ' THR . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt -60.45 150.19 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -154.41 57.84 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' NZ ' ' CE2' ' A' ' 45' ' ' PHE . 30.1 mmtp -100.68 -16.32 17.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 54.24 67.74 0.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.521 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.6 mp -86.87 117.39 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.149 -0.969 . . . . 0.0 109.313 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.672 HH11 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt -116.15 139.45 50.31 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -86.49 139.03 31.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.2 9.54 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.521 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 23.7 t-20 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 71' ' ' LEU . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 HE21 HD21 ' A' ' 71' ' ' LEU . 40.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 64' ' ' GLU . 63.2 mt -60.64 150.08 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -71.43 -61.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -81.28 -30.8 33.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 61' ' ' ILE . 80.9 tt0 46.84 -112.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.407 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -88.35 117.78 27.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 30' ' ' ILE . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 125.42 51.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -60.34 134.51 57.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.07 -164.72 53.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.504 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 73' ' ' LEU . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' THR . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 51' ' ' GLU . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 75.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' THR . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 64' ' ' GLU . 46.8 mt -60.98 144.66 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.44 -59.18 2.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -73.7 -28.49 61.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.648 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.628 ' H ' HG22 ' A' ' 61' ' ' ILE . 88.3 tt0 52.74 81.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.546 HD11 HD13 ' A' ' 61' ' ' ILE . 68.6 mt -87.54 158.25 18.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' C ' HD12 ' A' ' 69' ' ' LEU . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 68' ' ' HIS . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.422 ' H ' HD11 ' A' ' 8' ' ' LEU . 48.5 tp -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -67.96 -37.66 81.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.229 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.13 89.5 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.489 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG2' HD13 ' A' ' 69' ' ' LEU . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 7' ' ' THR . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 13' ' ' ILE . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 21' ' ' ASP . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.834 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.834 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.61 ' N ' HG22 ' A' ' 55' ' ' THR . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 55' ' ' THR . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.55 136.51 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.46 -53.51 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.023 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 64' ' ' GLU . 41.9 mmtm -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.932 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 pt-20 32.06 68.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.288 0.566 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.453 ' O ' HG22 ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 56' ' ' LEU . 27.4 mt -114.64 117.54 31.14 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.476 -0.765 . . . . 0.0 109.682 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 74' ' ' ARG . 25.3 mt -84.64 165.51 17.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 73' ' ' LEU . 67.0 ttt180 59.56 151.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.626 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.22 161.09 34.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.529 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 ' CG2' HD13 ' A' ' 69' ' ' LEU . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' HD12 ' A' ' 56' ' ' LEU . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 57.5 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.438 HH12 ' CD ' ' A' ' 74' ' ' ARG . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.538 ' N ' HG22 ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 64' ' ' GLU . 61.6 mt -61.18 131.29 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -69.98 -50.72 38.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 64' ' ' GLU . 33.3 mtmm -65.7 -31.77 72.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.992 -1.067 . . . . 0.0 110.037 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 82.1 tt0 41.54 66.17 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -0.783 . . . . 0.0 110.258 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.6 122.92 41.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt -114.98 144.86 42.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' CD ' HH12 ' A' ' 42' ' ' ARG . 54.3 ttt85 -170.83 136.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.122 -0.986 . . . . 0.0 109.517 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.38 -176.0 47.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.509 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 8' ' ' LEU . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG22 ' A' ' 7' ' ' THR . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 56' ' ' LEU . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 55' ' ' THR . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.6 t-20 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 44' ' ' ILE . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 56' ' ' LEU . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' N ' HG22 ' A' ' 55' ' ' THR . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.85 132.29 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 27.0 mp0 -60.38 -50.04 75.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.644 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 64' ' ' GLU . 63.3 mttp -64.61 -24.74 67.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.091 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' LYS . 19.6 pt-20 37.32 43.42 0.37 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.599 -0.688 . . . . 0.0 110.792 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.24 152.71 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 0.0 109.74 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' C ' HD12 ' A' ' 69' ' ' LEU . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.3 mp -93.19 134.15 35.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -59.6 -44.4 93.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.347 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 76' ' ' GLY . . . -163.21 -1.5 0.05 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 75' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.558 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' ILE . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 51' ' ' GLU . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' O ' HD12 ' A' ' 23' ' ' ILE . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.569 ' N ' HG22 ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 55' ' ' THR . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 67' ' ' LEU . 13.6 pt -60.47 146.22 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.93 43.99 1.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.506 -0.746 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' SEP . 30.6 mmtp -103.13 -1.05 29.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.436 -0.79 . . . . 0.0 109.268 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 62.9 -70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 109.551 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.462 ' CG2' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 61' ' ' ILE . 28.4 mt -89.81 117.62 28.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' NE2' ' CG2' ' A' ' 66' ' ' TPO . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.41 166.02 11.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.21 -28.58 69.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.99 -173.88 46.55 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.991 -1.45 . . . . 0.0 109.586 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 69' ' ' LEU . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 70' ' ' VAL . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 14' ' ' THR . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' VAL . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 20' ' ' SER . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -85.35 150.3 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -153.09 75.24 1.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.416 -0.802 . . . . 0.0 109.086 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HZ3' ' HB2' ' A' ' 46' ' ' ALA . 88.5 tttt -108.47 -30.3 8.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.718 . . . . 0.0 109.91 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -174.57 158.57 2.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -89.48 123.97 34.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 109.598 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HD12 ' A' ' 69' ' ' LEU . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt -89.76 143.76 26.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 49.34 -153.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.22 -161.3 31.96 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 7' ' ' THR . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 16' ' ' GLU . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.711 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.711 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -92.14 126.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -150.95 -48.88 0.12 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.013 -1.054 . . . . 0.0 109.71 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.03 -7.19 10.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -0.996 . . . . 0.0 109.38 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' SEP . 74.4 mm-40 -87.75 70.98 9.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -78.64 117.79 20.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt -112.37 140.23 47.27 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -159.49 146.45 16.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.94 3.71 90.5 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.536 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 9' ' ' THR . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 17' ' ' VAL . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 16' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 57' ' ' SER . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 55' ' ' THR . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -59.68 139.33 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.94 -67.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.279 -0.888 . . . . 0.0 110.783 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' C ' ' H ' ' A' ' 65' ' ' SEP . 69.0 mttm -80.48 -31.4 37.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.543 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.45 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 109.549 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.615 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -67.2 119.54 12.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.56 ' C ' HD12 ' A' ' 69' ' ' LEU . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.3 mp -97.68 125.92 42.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 46.77 63.17 2.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 109.68 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.19 95.32 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.498 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 21' ' ' ASP . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 17' ' ' VAL . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 17' ' ' VAL . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.677 HH11 HH22 ' A' ' 74' ' ' ARG . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -72.59 150.38 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.81 70.25 1.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.24 -29.74 8.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 65' ' ' SEP . 88.3 tt0 -172.32 153.99 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.418 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.48 119.82 31.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.502 ' C ' HD12 ' A' ' 69' ' ' LEU . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.02 160.5 14.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.677 HH22 HH11 ' A' ' 42' ' ' ARG . 66.1 ttt180 -152.37 122.2 6.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.336 -0.853 . . . . 0.0 109.271 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.77 101.86 0.25 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.565 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' THR . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.55 ' ND2' ' NZ ' ' A' ' 29' ' ' LYS . 3.5 t-20 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.55 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.544 HH11 ' C ' ' A' ' 75' ' ' GLY . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 23' ' ' ILE . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 55' ' ' THR . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' H ' ' A' ' 64' ' ' GLU . 6.2 tp -67.17 150.31 11.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -88.16 -51.03 6.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.713 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 64' ' ' GLU . 61.8 tttp -65.42 -32.02 73.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.943 -1.098 . . . . 0.0 110.292 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' HG13 ' A' ' 61' ' ' ILE . 77.6 tt0 41.87 61.87 1.77 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.332 -0.855 . . . . 0.0 110.418 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.29 148.07 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp -104.45 158.39 16.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LEU . 55.8 ttm-85 59.86 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' C ' HH11 ' A' ' 42' ' ' ARG . . . 159.49 53.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.615 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' H ' ' HA ' ' A' ' 16' ' ' GLU . 52.0 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE1' ' O1P' ' A' ' 66' ' ' TPO . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 55' ' ' THR . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.636 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 52.5 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.0 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG22 ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.01 150.24 6.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.02 40.37 2.71 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.494 -0.754 . . . . 0.0 109.083 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -88.74 -26.31 21.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 0.0 109.239 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 52.7 46.37 26.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.44 ' O1P' ' CE1' ' A' ' 4' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.0 117.38 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 70' ' ' VAL . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -113.94 143.54 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -146.68 130.51 17.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.16 83.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 73' ' ' LEU . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 55' ' ' THR . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.24 150.28 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -143.78 76.65 1.52 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.355 -0.841 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -97.56 -3.34 39.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 98.5 mt-10 50.72 45.71 26.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.405 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' TPO . 19.9 mt -93.78 117.09 29.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.572 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 8' ' ' LEU . 50.8 mt -112.03 136.0 51.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 48.4 mtm180 -99.99 140.96 33.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.309 -0.869 . . . . 0.0 109.249 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.17 1.74 90.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 13' ' ' ILE . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' OD2' ' A' ' 21' ' ' ASP . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' GLY . 54.1 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.788 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.788 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' CD1' ' H ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -84.94 116.81 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.83 -38.02 13.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.125 -0.984 . . . . 0.0 110.33 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 65' ' ' SEP . 63.6 mttp -69.69 -31.79 70.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.099 . . . . 0.0 110.221 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' H ' ' CD1' ' A' ' 61' ' ' ILE . 98.9 mt-10 43.26 19.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.419 -0.8 . . . . 0.0 110.125 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.66 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.07 139.99 35.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.491 ' C ' HD12 ' A' ' 69' ' ' LEU . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -113.0 141.92 46.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -71.96 -48.12 47.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.15 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.35 15.53 70.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.566 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 12.8 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.61 119.4 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -89.34 65.33 7.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -80.6 -30.32 36.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 52.18 56.14 8.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.434 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.58 117.66 23.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 125.03 50.08 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.46 160.34 31.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.27 4.05 90.33 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 CA-C-O 117.929 -1.484 . . . . 0.0 109.536 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 11' ' ' LYS . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' THR . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' A' ' 25' ' ' ASN . 5.2 m120 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 55' ' ' THR . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt -81.83 128.95 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.76 64.74 5.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.898 . . . . 0.0 109.198 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' NZ ' ' H ' ' A' ' 68' ' ' HIS . 19.9 tptm -71.25 -30.35 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 52.85 36.16 20.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.158 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.503 ' OG ' ' N ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.503 ' N ' ' OG ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt -90.09 117.65 29.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.411 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -85.89 126.15 33.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 51.66 -117.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.416 -0.803 . . . . 0.0 109.673 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.82 -168.29 50.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.522 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 ' HZ2' ' A' ' 33' ' ' LYS . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' THR . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 50' ' ' LEU . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 25' ' ' ASN . 6.1 m120 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 74' ' ' ARG . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.98 134.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.12 -53.15 59.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' GLU . 68.6 mttm -64.64 -32.07 73.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.032 -1.042 . . . . 0.0 110.24 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 75.7 tt0 43.06 58.93 3.1 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TPO . . . . . 0.452 ' N ' ' CE ' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -172.01 158.09 4.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' H ' HD23 ' A' ' 67' ' ' LEU . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 74' ' ' ARG . 51.4 mt -81.23 125.65 30.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' GLN . 54.5 ttp180 57.37 162.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.434 -0.792 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.64 -173.93 44.5 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.601 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.583 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 29' ' ' LYS . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 20' ' ' SER . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 56' ' ' LEU . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 70' ' ' VAL . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 3.3 t30 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 29.1 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' C ' HD12 ' A' ' 69' ' ' LEU . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 9.1 mp . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.672 HD11 HH11 ' A' ' 72' ' ' ARG . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD2' HG11 ' A' ' 17' ' ' VAL . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 69.8 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.626 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.67 ' N ' HG22 ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 55' ' ' THR . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.6 mp . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.672 HH11 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt . . . . . 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.576 HD21 ' CE ' ' A' ' 29' ' ' LYS . 21.6 t30 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' CE ' HD21 ' A' ' 25' ' ' ASN . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 71' ' ' LEU . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.2 mt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.285 0.564 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 30' ' ' ILE . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 73' ' ' LEU . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' THR . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 51' ' ' GLU . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.2 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 33.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.433 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' THR . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 HD13 HD11 ' A' ' 67' ' ' LEU . 46.8 mt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.546 HD11 HD13 ' A' ' 61' ' ' ILE . 68.6 mt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.441 0.638 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.447 ' C ' HD12 ' A' ' 69' ' ' LEU . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 68' ' ' HIS . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.422 ' H ' HD11 ' A' ' 8' ' ' LEU . 48.5 tp . . . . . 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG2' HD13 ' A' ' 69' ' ' LEU . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 7' ' ' THR . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 13' ' ' ILE . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 21' ' ' ASP . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.834 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.834 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.61 ' N ' HG22 ' A' ' 55' ' ' THR . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 55' ' ' THR . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 56' ' ' LEU . 27.4 mt . . . . . 0 N--CA 1.5 2.062 0 CA-C-O 121.425 0.631 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 ' CG2' HD13 ' A' ' 69' ' ' LEU . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' HD12 ' A' ' 56' ' ' LEU . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 35.1 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.538 ' N ' HG22 ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.355 0.598 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 8' ' ' LEU . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG22 ' A' ' 7' ' ' THR . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 56' ' ' LEU . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 55' ' ' THR . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 39.1 t30 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 44' ' ' ILE . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 56' ' ' LEU . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.552 ' N ' HG22 ' A' ' 55' ' ' THR . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 13.9 t-20 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.355 0.598 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' C ' HD12 ' A' ' 69' ' ' LEU . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.3 mp . . . . . 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' ILE . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 51' ' ' GLU . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' O ' HD12 ' A' ' 23' ' ' ILE . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.569 ' N ' HG22 ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 55' ' ' THR . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 67' ' ' LEU . 13.6 pt . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 61' ' ' ILE . 28.4 mt . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' C ' HD12 ' A' ' 69' ' ' LEU . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 69' ' ' LEU . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 70' ' ' VAL . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 14' ' ' THR . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' VAL . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 20' ' ' SER . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.229 0.537 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HD12 ' A' ' 69' ' ' LEU . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 7' ' ' THR . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 16' ' ' GLU . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.711 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.711 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt . . . . . 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 9' ' ' THR . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 17' ' ' VAL . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 16' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.488 ' OG1' ' ND2' ' A' ' 25' ' ' ASN . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 22' ' ' THR . 42.6 m-80 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 57' ' ' SER . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 55' ' ' THR . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.56 ' C ' HD12 ' A' ' 69' ' ' LEU . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.3 mp . . . . . 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 21' ' ' ASP . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 17' ' ' VAL . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 17' ' ' VAL . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.502 ' C ' HD12 ' A' ' 69' ' ' LEU . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' THR . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.2 t30 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 23' ' ' ILE . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 55' ' ' THR . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.244 0.545 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp . . . . . 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.428 ' H ' ' HA ' ' A' ' 16' ' ' GLU . 7.7 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 55' ' ' THR . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.636 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.536 HG21 HE22 ' A' ' 41' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.8 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.536 HE22 HG21 ' A' ' 30' ' ' ILE . 28.5 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG22 ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 70' ' ' VAL . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 73' ' ' LEU . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 55' ' ' THR . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 8' ' ' LEU . 50.8 mt . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 13' ' ' ILE . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' OD2' ' A' ' 21' ' ' ASP . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.788 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.788 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' H ' HG22 ' A' ' 61' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.318 0.58 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.491 ' C ' HD12 ' A' ' 69' ' ' LEU . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 48.3 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 6.6 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.311 0.577 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 11' ' ' LYS . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' THR . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 55' ' ' THR . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 ' HZ2' ' A' ' 33' ' ' LYS . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' THR . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.537 ' H ' HD22 ' A' ' 25' ' ' ASN . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 50' ' ' LEU . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.537 HD22 ' H ' ' A' ' 22' ' ' THR . 83.7 m-20 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 68' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' H ' HD23 ' A' ' 67' ' ' LEU . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.583 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.4 mp0 -85.07 83.14 8.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.2 mt -70.75 132.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.925 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -86.46 148.33 25.59 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.262 -0.899 . . . . 0.0 110.203 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.2 t -141.72 102.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -102.74 134.49 46.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.824 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -99.49 163.11 12.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.417 -0.802 . . . . 0.0 109.114 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 8' ' ' LEU . 9.5 mp -61.58 -27.52 68.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.085 -1.009 . . . . 0.0 109.418 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.4 p -78.93 0.64 26.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.147 -0.971 . . . . 0.0 109.474 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -14.11 60.33 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.57 107.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.7 m -92.76 148.5 21.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.232 -0.917 . . . . 0.0 109.601 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.0 mt -142.61 139.31 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -116.76 127.1 54.04 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.308 -0.87 . . . . 0.0 109.222 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -118.44 115.9 25.59 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.92 112.42 24.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.253 -0.904 . . . . 0.0 108.632 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' CG ' ' A' ' 21' ' ' ASP . 5.6 p -161.27 150.78 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.1 -1.0 . . . . 0.0 110.224 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' SER . 97.8 mt-10 -63.64 120.47 63.27 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.557 -0.715 . . . . 0.0 109.852 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.85 -15.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.183 1.922 . . . . 0.0 113.168 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 55' ' ' THR . 64.9 p -74.82 -16.32 60.7 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.772 -1.205 . . . . 0.0 109.272 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' CG ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -55.51 157.76 3.73 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -79.02 167.82 20.54 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.797 -1.189 . . . . 0.0 109.73 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.583 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -74.89 -47.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.151 -0.968 . . . . 0.0 108.951 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.96 -22.63 50.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.454 -0.779 . . . . 0.0 108.909 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.9 t30 -70.87 -44.93 65.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' ALA . 39.7 t -62.34 -64.06 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 58.1 mttp -40.85 -24.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.406 0.622 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.51 -57.08 6.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 109.014 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 29' ' ' LYS . 46.8 mmtt -51.82 -27.6 12.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 31' ' ' GLN . 90.6 mt -84.01 -63.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.12 -0.987 . . . . 0.0 109.411 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.4 tt0 -39.14 -45.79 1.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.671 -0.643 . . . . 0.0 110.991 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.76 -53.97 13.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.166 -0.959 . . . . 0.0 110.124 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -39.37 83.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.488 -0.758 . . . . 0.0 110.719 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -93.78 -28.83 15.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.759 -1.213 . . . . 0.0 109.86 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 76.41 23.79 69.79 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.84 99.33 34.1 Favored Pre-proline 0 N--CA 1.485 1.311 0 O-C-N 121.559 -0.965 . . . . 0.0 109.743 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' A' ' 39' ' ' ASP . 83.3 Cg_exo -47.2 121.71 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.956 1.771 . . . . 0.0 111.907 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -40.19 -18.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.363 2.042 . . . . 0.0 112.821 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.9 m-20 -59.19 -44.19 92.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.968 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -88.22 13.07 12.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 110.423 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -132.81 141.56 48.54 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -133.04 128.05 35.43 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.37 145.82 25.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.654 -1.279 . . . . 0.0 110.455 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.58 134.54 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -148.78 110.08 4.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.917 -1.114 . . . . 0.0 109.8 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.25 10.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.57 -0.706 . . . . 0.0 111.525 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.44 0.26 67.52 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.578 -1.326 . . . . 0.0 110.792 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.77 151.08 47.19 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.256 -1.143 . . . . 0.0 109.192 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.47 166.39 12.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.0 -1.062 . . . . 0.0 108.755 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 mt -99.58 135.51 40.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.008 -1.058 . . . . 0.0 108.657 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.7 mt-10 -93.65 157.07 16.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.16 -0.963 . . . . 0.0 110.119 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.48 156.21 37.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.434 -0.792 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 76.29 -173.29 54.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.6 mtt85 56.19 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.398 -1.06 . . . . 0.0 110.058 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 20' ' ' SER . 28.8 p -120.21 171.65 8.34 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 56' ' ' LEU . 6.8 mp -67.52 -48.61 66.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 108.915 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -63.27 -50.23 70.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.871 -1.143 . . . . 0.0 108.146 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 55' ' ' THR . 16.1 t70 -51.26 -29.87 15.93 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.65 -0.656 . . . . 0.0 109.597 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -73.64 -21.52 60.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.874 -1.141 . . . . 0.0 108.509 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.4 m120 69.95 62.93 0.24 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.347 -0.845 . . . . 0.0 109.97 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mm -60.48 150.41 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 108.96 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.55 -56.4 5.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 110.438 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' C ' ' H ' ' A' ' 65' ' ' SEP . 66.8 mmtt -76.71 -30.59 56.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 0.0 110.116 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 50.41 9.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.063 -1.023 . . . . 0.0 109.582 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.736 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -86.26 124.66 32.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -105.59 130.48 53.63 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.572 -0.705 . . . . 0.0 109.612 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.2 mt -131.84 149.84 52.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 70' ' ' VAL . 26.7 m -135.43 124.8 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.148 -0.97 . . . . 0.0 108.911 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.66 144.54 30.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -121.13 163.35 18.56 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.505 -0.747 . . . . 0.0 109.036 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt -95.52 165.37 12.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.051 -1.031 . . . . 0.0 109.566 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 74' ' ' ARG . 0.5 OUTLIER -104.84 119.83 39.94 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.76 -173.38 52.51 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -80.94 106.9 13.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -84.36 132.0 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.53 153.06 20.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -141.69 106.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.243 -0.911 . . . . 0.0 108.978 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -100.79 126.73 47.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.495 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.4 p -93.62 173.64 7.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 109.412 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.9 -35.17 79.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.265 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -78.56 -1.87 36.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 -11.52 71.92 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -48.2 110.82 0.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -1.19 . . . . 0.0 109.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.71 141.45 28.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 0.0 109.905 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -142.13 137.48 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -119.05 135.75 54.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.396 -0.815 . . . . 0.0 109.564 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -125.38 116.55 22.05 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.79 113.36 25.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.195 -0.94 . . . . 0.0 109.75 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 p -160.79 152.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 109.417 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -45.14 150.96 0.72 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.437 -0.789 . . . . 0.0 109.684 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.89 -11.13 27.23 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.316 2.011 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 55' ' ' THR . 5.8 p -92.66 11.6 26.16 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.045 -1.034 . . . . 0.0 109.584 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 24.7 t0 -52.44 166.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 108.913 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.7 p -96.12 174.42 6.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.13 -0.981 . . . . 0.0 109.139 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.3 mt -77.93 -50.7 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.883 -1.136 . . . . 0.0 108.92 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -55.32 -24.19 27.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.611 -0.68 . . . . 0.0 109.465 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 3.3 t30 -71.62 -46.27 59.66 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 27' ' ' LYS . 47.2 t -59.08 -64.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 66.3 mttm -40.61 -33.46 0.28 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.319 0.58 . . . . 0.0 110.052 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.25 -58.76 5.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 109.329 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 42.9 mttm -50.75 -29.22 10.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.365 -0.835 . . . . 0.0 109.497 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.4 mp -79.13 -64.0 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -39.78 -49.5 2.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.769 -0.582 . . . . 0.0 111.103 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -72.2 -54.48 9.53 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.143 -0.973 . . . . 0.0 111.012 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.6 -43.14 89.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 0.0 110.833 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.19 -21.12 23.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.767 -1.208 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.65 13.25 71.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.5 mt -96.1 135.9 22.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.564 -0.963 . . . . 0.0 109.243 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.98 121.73 7.54 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.569 1.513 . . . . 0.0 111.579 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.1 Cg_exo -39.51 -30.09 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.502 2.135 . . . . 0.0 113.317 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -40.8 70.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.685 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -87.89 6.73 34.17 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.318 -0.863 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 38' ' ' PRO . 29.1 mt-30 -136.51 138.13 41.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.255 -0.903 . . . . 0.0 110.26 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -132.3 136.68 47.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.67 137.88 31.92 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.036 -1.04 . . . . 0.0 110.2 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -116.56 133.68 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 47.7 t80 -147.1 102.84 3.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.894 -1.129 . . . . 0.0 109.882 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.38 30.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 111.65 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.1 1.72 84.23 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.559 -1.338 . . . . 0.0 110.359 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.41 152.02 48.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.415 -1.05 . . . . 0.0 108.936 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -102.6 169.02 8.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.122 -0.986 . . . . 0.0 108.652 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -100.41 112.38 24.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.973 -1.08 . . . . 0.0 108.929 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.52 138.34 31.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.147 -0.971 . . . . 0.0 109.703 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.4 p30 -57.11 156.54 7.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.364 -0.835 . . . . 0.0 109.643 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.13 41.54 6.2 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -170.82 155.96 4.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.356 -1.085 . . . . 0.0 110.335 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 20' ' ' SER . 9.7 m -120.29 152.25 38.06 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -46.45 -43.44 16.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.89 -1.131 . . . . 0.0 110.051 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.8 p -53.91 -58.36 7.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -52.43 -36.33 54.23 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.32 2.3 9.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 108.606 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 36.98 63.23 0.71 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.901 -0.499 . . . . 0.0 111.561 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.56 118.51 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.0 108.86 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.06 48.99 0.86 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 110.1 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 65' ' ' SEP . 64.7 mttm -108.31 10.28 27.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.402 -0.811 . . . . 0.0 109.112 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 63.07 -70.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.631 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.524 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 67' ' ' LEU . 7.8 mp -84.93 117.98 24.26 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -0.891 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' C ' HD12 ' A' ' 69' ' ' LEU . 55.9 p-80 -112.89 135.82 53.23 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.666 -0.646 . . . . 0.0 109.268 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -127.01 153.16 46.28 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -134.53 118.52 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.159 -0.963 . . . . 0.0 108.815 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.43 148.74 25.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.126 -0.984 . . . . 0.0 109.513 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -116.61 151.69 35.73 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 9.1 mp -99.8 150.35 22.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.058 -1.026 . . . . 0.0 109.317 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 46.87 55.01 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.275 -0.891 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.55 -38.89 95.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 17' ' ' VAL . 64.8 mtt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.52 78.52 6.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.396 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.38 142.22 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.26 135.37 50.45 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.554 -0.716 . . . . 0.0 109.082 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -135.44 135.04 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.0 108.553 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -119.81 147.76 44.27 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.512 -0.742 . . . . 0.0 109.886 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -107.04 -176.18 3.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.672 HD11 HH11 ' A' ' 72' ' ' ARG . 8.1 mp -71.56 -27.93 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -0.983 . . . . 0.0 109.579 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.2 p -78.9 -1.89 37.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.622 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.8 68.09 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -51.97 118.1 3.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.055 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -97.56 133.07 42.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.309 -0.869 . . . . 0.0 109.856 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.2 pt -142.84 139.85 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 p -130.34 145.11 51.74 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.337 -0.852 . . . . 0.0 109.22 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -119.46 114.87 22.97 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -90.21 110.36 21.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.827 -1.17 . . . . 0.0 109.272 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 1' ' ' MET . 6.6 p -164.26 156.13 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.5 mt-10 -45.81 149.75 1.1 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.104 -0.997 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.38 -16.96 27.54 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.287 1.991 . . . . 0.0 112.702 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -77.35 18.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.041 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD2' HG11 ' A' ' 17' ' ' VAL . 6.3 m-20 -68.15 142.25 55.8 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.071 -1.018 . . . . 0.0 109.27 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -82.47 146.36 29.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.454 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 51' ' ' GLU . 88.7 mt -44.93 -54.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.959 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -47.36 -30.96 3.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.25 -0.906 . . . . 0.0 109.662 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 23.5 t30 -66.44 -47.64 72.51 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 108.703 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -55.03 -63.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 60.3 mttm -40.81 -32.82 0.24 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.212 0.53 . . . . 0.0 110.397 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.38 -58.48 3.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.246 -0.909 . . . . 0.0 110.4 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 14.4 mptt -53.2 -26.9 19.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -84.64 -64.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.036 -1.04 . . . . 0.0 109.37 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.1 tm0? -39.0 -47.51 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.711 -0.618 . . . . 0.0 111.307 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' NE2' ' A' ' 31' ' ' GLN . 70.1 m-20 -70.29 -54.1 14.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 110.459 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -58.37 -39.84 80.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.0 109.982 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -91.45 -22.36 20.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.636 -1.29 . . . . 0.0 109.06 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.64 11.44 68.84 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.91 135.23 25.02 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.475 -1.015 . . . . 0.0 109.15 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' ASP . 73.2 Cg_endo -74.61 122.37 7.34 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.791 1.661 . . . . 0.0 111.732 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.8 Cg_exo -39.09 -27.21 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 112.915 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -54.47 -40.12 68.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.855 . . . . 0.0 109.628 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -90.27 7.69 37.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 110.169 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 69.8 mt-30 -136.69 140.85 42.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -133.84 137.5 45.08 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.3 mp -88.17 139.09 30.86 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.012 -1.055 . . . . 0.0 109.708 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -126.62 134.59 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.626 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 64.1 t80 -151.17 102.72 2.96 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.84 -1.162 . . . . 0.0 109.55 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 74.65 23.45 1.84 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.497 -0.752 . . . . 0.0 111.091 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.13 7.84 72.89 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.748 -1.22 . . . . 0.0 110.302 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -126.41 148.03 49.69 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.431 -1.04 . . . . 0.0 109.038 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -95.43 165.48 12.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.957 -1.09 . . . . 0.0 108.661 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 mt -105.54 119.66 39.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.078 -1.014 . . . . 0.0 108.615 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.0 mm-40 -93.43 140.13 29.92 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.11 -0.994 . . . . 0.0 110.027 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -45.78 151.12 0.46 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.735 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 86.21 -172.42 45.35 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' NH1' ' CE1' ' A' ' 59' ' ' TYR . 48.7 ttp180 58.23 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.754 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 56' ' ' LEU . 96.1 m -120.7 175.67 5.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.67 ' N ' HG22 ' A' ' 55' ' ' THR . 10.3 mp -66.78 -45.81 77.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.881 -1.137 . . . . 0.0 109.051 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -59.21 -51.88 68.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.012 -1.055 . . . . 0.0 108.164 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 55' ' ' THR . 99.1 m-20 -54.68 -27.49 40.58 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CE1' ' NH1' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.86 -17.1 61.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 55.79 47.78 19.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.737 . . . . 0.0 109.423 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt -60.45 150.19 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.268 -0.895 . . . . 0.0 109.764 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -154.41 57.84 0.7 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.926 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' NZ ' ' CE2' ' A' ' 45' ' ' PHE . 30.1 mmtp -100.68 -16.32 17.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 54.24 67.74 0.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.521 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.6 mp -86.87 117.39 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.149 -0.969 . . . . 0.0 109.313 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -129.92 127.52 40.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.57 -0.706 . . . . 0.0 109.336 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 mt -115.16 166.49 11.77 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.21 124.73 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.977 -1.077 . . . . 0.0 108.848 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.14 148.93 29.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.154 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.672 HH11 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -119.24 163.2 17.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.6 mt -116.15 139.45 50.31 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.947 . . . . 0.0 109.154 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -86.49 139.03 31.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.2 9.54 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.987 -1.452 . . . . 0.0 109.521 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.35 87.64 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.405 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.32 134.82 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -78.77 136.11 37.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -141.58 102.25 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 109.075 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -117.07 152.12 35.35 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.502 -0.749 . . . . 0.0 109.611 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -107.66 -174.65 2.58 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 0.0 109.103 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.1 mt -75.44 -15.61 60.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.9 p -85.08 -3.38 58.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.33 -15.99 58.6 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.77 113.32 0.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -92.88 141.83 27.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.967 . . . . 0.0 109.697 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -142.54 139.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -126.05 135.65 52.01 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.71 115.76 25.16 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -90.98 111.81 23.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 109.891 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.75 151.01 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 20' ' ' SER . 13.5 mm-40 -45.96 126.5 6.99 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 109.505 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -40.34 -19.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.913 1.742 . . . . 0.0 112.547 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 18' ' ' GLU . 66.2 p -77.45 8.72 3.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.677 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -47.6 161.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.269 -0.894 . . . . 0.0 109.119 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 p -96.96 175.02 6.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.024 . . . . 0.0 109.348 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -84.18 -40.25 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.72 -27.92 68.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.576 HD21 ' CE ' ' A' ' 29' ' ' LYS . 21.6 t30 -67.93 -47.96 67.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.65 -64.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -40.95 -34.63 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.422 0.629 . . . . 0.0 109.787 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.19 -57.22 5.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.482 -0.761 . . . . 0.0 109.678 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' CE ' HD21 ' A' ' 25' ' ' ASN . 42.4 mttm -48.74 -30.37 5.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 71' ' ' LEU . 25.9 mm -80.34 -59.23 3.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.162 -0.962 . . . . 0.0 108.499 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 32' ' ' ASP . 15.0 tm0? -38.59 -51.17 1.63 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.804 -0.56 . . . . 0.0 111.222 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' OE1' ' A' ' 31' ' ' GLN . 58.8 m-20 -72.14 -53.71 11.91 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.42 -0.8 . . . . 0.0 111.023 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.3 mmmm -59.41 -44.56 92.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 111.117 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -88.04 -30.89 19.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.808 -1.183 . . . . 0.0 109.588 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.34 11.12 78.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 53.5 mt -91.19 135.58 28.19 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.602 -0.94 . . . . 0.0 109.025 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.2 Cg_endo -74.7 121.67 6.84 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.632 1.555 . . . . 0.0 111.649 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -41.18 -15.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.485 2.124 . . . . 0.0 112.779 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.2 m-20 -66.9 -39.51 87.45 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.617 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -94.36 14.52 20.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.471 -0.768 . . . . 0.0 110.558 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -126.26 138.31 53.6 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.143 -0.973 . . . . 0.0 109.804 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -133.93 130.9 38.39 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.3 mp -88.81 145.08 25.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.006 -1.059 . . . . 0.0 109.875 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -122.71 133.43 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -148.74 121.17 8.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.738 -1.226 . . . . 0.0 110.015 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.8 24.08 1.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.667 -0.646 . . . . 0.0 111.627 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.34 70.09 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 120.547 -1.345 . . . . 0.0 110.493 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -126.24 151.87 46.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.159 -1.2 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -96.38 169.5 9.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.069 -1.02 . . . . 0.0 109.471 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -100.58 138.69 37.3 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.229 -0.919 . . . . 0.0 108.948 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -93.53 156.96 16.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.105 -0.997 . . . . 0.0 109.534 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.6 p-10 -57.86 156.12 9.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 67.1 -156.02 52.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 53' ' ' GLY . 82.1 mtt85 56.75 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.755 -0.85 . . . . 0.0 110.134 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.3 m -122.51 163.42 19.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 55' ' ' THR . 45.5 mt -65.47 -50.95 63.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.842 -1.161 . . . . 0.0 109.239 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.8 p -61.48 -51.85 66.97 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.094 -1.004 . . . . 0.0 108.403 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 66.7 t0 -52.31 -26.68 12.77 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.513 -0.742 . . . . 0.0 109.275 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -21.75 60.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 108.281 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.45 62.31 1.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.713 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 64' ' ' GLU . 63.2 mt -60.64 150.08 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -71.43 -61.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -81.28 -30.8 33.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' HG22 ' A' ' 61' ' ' ILE . 80.9 tt0 46.84 -112.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.407 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 mt -88.35 117.78 27.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -105.61 129.51 53.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.551 -0.718 . . . . 0.0 109.307 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.6 mt -129.87 151.0 50.91 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.499 -0.751 . . . . 0.0 109.048 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.7 t -133.09 116.3 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 30' ' ' ILE . 7.0 tt -89.67 148.62 23.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.139 -0.976 . . . . 0.0 109.875 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -125.71 145.77 50.04 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 125.42 51.18 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.27 -0.894 . . . . 0.0 109.097 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -60.34 134.51 57.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.07 -164.72 53.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.504 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.7 92.56 3.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.64 133.22 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.586 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -113.86 142.84 45.61 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.516 -0.74 . . . . 0.0 109.289 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.94 138.85 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.054 -1.029 . . . . 0.0 108.694 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -116.81 143.94 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.368 -0.832 . . . . 0.0 109.726 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -101.89 177.49 4.89 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 73' ' ' LEU . 61.6 mt -63.18 -30.29 71.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' THR . 49.6 m -79.74 -6.77 57.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.54 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.7 -7.66 79.3 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -48.16 115.36 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -1.105 . . . . 0.0 109.279 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -95.98 132.95 40.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 109.946 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.79 129.53 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.05 128.61 55.53 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.13 -0.981 . . . . 0.0 109.273 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.02 114.43 22.0 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.5 121.88 45.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.472 -0.767 . . . . 0.0 109.231 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -162.96 152.09 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.577 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -42.74 110.61 0.89 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.638 -0.664 . . . . 0.0 109.865 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -44.0 -20.12 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.183 1.922 . . . . 0.0 113.171 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -74.25 3.14 7.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.596 -1.315 . . . . 0.0 109.046 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -70.51 142.95 51.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.457 -0.777 . . . . 0.0 108.921 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.0 p -78.51 149.75 33.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 51' ' ' GLU . 79.0 mt -50.07 -47.36 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -47.21 -35.49 7.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.3 t30 -66.26 -39.23 89.32 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.8 t -66.73 -62.62 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' ' CD1' ' A' ' 43' ' ' LEU . 66.0 mttm -46.48 -30.6 2.27 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.591 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -58.25 4.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -55.01 -27.46 44.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 31' ' ' GLN . 89.7 mt -78.36 -65.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.2 tt0 -40.05 -43.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.821 -0.549 . . . . 0.0 110.366 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.46 -53.39 19.49 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.316 -0.865 . . . . 0.0 109.787 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.62 -39.31 80.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.544 -0.723 . . . . 0.0 110.761 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -94.35 -24.59 17.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.815 -1.178 . . . . 0.0 109.626 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.21 20.61 73.29 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -103.53 106.07 50.22 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.452 -1.028 . . . . 0.0 109.746 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.79 121.94 6.42 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.882 1.721 . . . . 0.0 111.938 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 41' ' ' GLN . 25.7 Cg_exo -39.18 -34.08 0.5 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.421 2.081 . . . . 0.0 113.273 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -50.8 -43.03 58.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -83.44 11.2 7.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.812 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' PRO . 33.2 mt-30 -139.74 143.69 37.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.367 -0.833 . . . . 0.0 110.538 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.4 mmt-85 -132.41 124.93 29.62 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 7.4 mt -88.26 141.7 28.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.659 -1.275 . . . . 0.0 110.207 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -123.79 134.45 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -150.56 114.32 4.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.053 -1.03 . . . . 0.0 109.122 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 20.79 10.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 110.549 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.37 5.95 78.6 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -127.49 149.79 49.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.359 -1.083 . . . . 0.0 109.319 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -90.11 160.87 16.06 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.956 -1.09 . . . . 0.0 108.797 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -100.56 114.57 28.33 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.124 -0.985 . . . . 0.0 108.817 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 23' ' ' ILE . 92.4 mt-10 -93.53 152.47 19.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.203 -0.935 . . . . 0.0 109.882 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 58.9 p-10 -74.16 156.63 37.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.352 -0.843 . . . . 0.0 109.516 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.85 41.52 3.54 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.621 ' NH1' ' CZ ' ' A' ' 59' ' ' TYR . 42.4 ttp180 -171.53 155.88 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -1.136 . . . . 0.0 109.191 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 69.6 p -119.19 -178.05 3.49 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.7 mp -70.85 -49.8 42.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.904 -1.122 . . . . 0.0 109.047 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -56.38 -54.42 45.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.861 -1.15 . . . . 0.0 107.951 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 55' ' ' THR . 65.5 t0 -52.21 -26.77 12.51 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.621 ' CZ ' ' NH1' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -74.33 -16.87 60.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 59.77 62.42 1.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.63 -0.669 . . . . 0.0 109.604 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 64' ' ' GLU . 46.8 mt -60.98 144.66 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 108.973 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.44 -59.18 2.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -73.7 -28.49 61.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.648 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.628 ' H ' HG22 ' A' ' 61' ' ' ILE . 88.3 tt0 52.74 81.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.546 HD11 HD13 ' A' ' 61' ' ' ILE . 68.6 mt -87.54 158.25 18.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' C ' HD12 ' A' ' 69' ' ' LEU . 77.6 m80 -124.22 129.34 50.62 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 68' ' ' HIS . 11.1 mp -110.81 165.63 11.69 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.74 112.97 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.082 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -82.77 147.47 28.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.061 -1.025 . . . . 0.0 108.838 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -122.92 163.05 21.07 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.422 ' H ' HD11 ' A' ' 8' ' ' LEU . 48.5 tp -113.08 135.89 53.3 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -67.96 -37.66 81.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.229 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.13 89.5 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.489 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -80.4 90.89 5.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.372 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG2' HD13 ' A' ' 69' ' ' LEU . 77.9 mt -72.81 127.86 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -85.85 150.69 24.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.402 -0.812 . . . . 0.0 110.177 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.77 102.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.569 -0.707 . . . . 0.0 109.342 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.26 121.14 33.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 8' ' ' LEU . 41.3 m -83.9 160.65 21.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.204 -0.935 . . . . 0.0 109.356 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 7' ' ' THR . 57.9 tp -62.96 -35.66 80.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 109.725 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -78.5 5.03 11.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.0 109.771 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.44 -18.56 51.77 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -57.4 87.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -1.127 . . . . 0.0 108.628 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' GLY . 99.7 m -92.91 118.07 30.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 110.007 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 95.8 mt -105.1 155.76 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.408 -0.807 . . . . 0.0 108.919 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 13' ' ' ILE . 93.8 m -116.71 129.49 56.16 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -116.18 113.86 23.65 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.494 -0.754 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -99.82 114.38 27.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.438 HG11 ' OD2' ' A' ' 21' ' ' ASP . 7.4 p -162.96 154.48 2.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.365 -0.834 . . . . 0.0 109.236 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 79.6 mm-40 -42.47 148.98 0.49 Allowed Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.547 -0.72 . . . . 0.0 109.578 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' C ' ' H ' ' A' ' 21' ' ' ASP . 57.8 Cg_endo -70.07 -23.39 29.41 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.265 1.977 . . . . 0.0 112.594 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -75.05 18.27 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.815 -1.178 . . . . 0.0 109.771 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -67.62 139.29 56.83 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.1 p -87.11 144.63 26.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 109.626 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -47.71 -46.88 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.291 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -58.02 -36.12 72.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.834 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 25.2 t-20 -67.32 -46.98 71.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.037 -1.04 . . . . 0.0 108.769 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.63 -63.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -41.59 -29.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.798 -0.564 . . . . 0.0 109.992 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -67.36 -57.96 5.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.225 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.834 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -51.35 -27.68 10.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.169 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.4 mt -81.4 -64.35 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.007 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 61.7 tt0 -38.82 -47.29 1.38 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.684 -0.635 . . . . 0.0 110.88 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -53.77 14.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.241 -0.912 . . . . 0.0 110.478 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 12.4 mmmt -59.45 -41.25 89.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 110.894 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 34.0 mm-40 -91.58 -31.69 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.674 -1.267 . . . . 0.0 109.88 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 79.76 21.99 65.02 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.3 mt -106.36 102.76 42.43 Favored Pre-proline 0 C--N 1.307 -1.269 0 O-C-N 121.526 -0.985 . . . . 0.0 109.764 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 39' ' ' ASP . 84.8 Cg_exo -47.57 121.3 5.42 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.912 1.741 . . . . 0.0 111.994 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -40.47 -20.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.369 2.046 . . . . 0.0 112.945 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.5 m-20 -60.73 -41.78 96.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.429 -0.794 . . . . 0.0 110.013 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -90.05 14.34 12.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 110.432 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -131.12 141.86 50.18 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' CA ' ' HE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -132.74 123.86 27.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.56 149.58 23.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.624 -1.298 . . . . 0.0 110.113 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.36 133.53 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -146.62 117.66 7.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.027 -1.046 . . . . 0.0 110.282 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.77 22.21 2.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.569 -0.707 . . . . 0.0 111.3 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.54 -3.48 68.58 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.6 -1.313 . . . . 0.0 110.358 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -125.65 151.66 46.24 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.306 -1.114 . . . . 0.0 109.009 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -91.64 166.98 12.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.0 -1.062 . . . . 0.0 109.342 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.9 mt -96.3 128.63 43.4 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.134 -0.979 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -101.28 158.09 16.3 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.371 -0.83 . . . . 0.0 109.95 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.12 156.73 29.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 109.392 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.53 27.07 30.93 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 53.9 mtp180 -147.71 147.08 29.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.529 -0.983 . . . . 0.0 109.626 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' LEU . 88.2 m -121.68 172.66 7.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.61 ' N ' HG22 ' A' ' 55' ' ' THR . 9.9 mp -67.16 -53.74 27.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.542 -1.349 . . . . 0.0 109.398 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 t -61.9 -44.71 96.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 108.5 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 55' ' ' THR . 18.5 t70 -59.37 -26.41 65.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.491 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -73.83 -21.51 60.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 108.447 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 55.54 58.82 4.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.417 -0.802 . . . . 0.0 109.717 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.55 136.51 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -0.961 . . . . 0.0 109.183 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -63.46 -53.51 50.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 110.023 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 64' ' ' GLU . 41.9 mmtm -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.932 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 63' ' ' LYS . 12.2 pt-20 32.06 68.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.288 0.566 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.453 ' O ' HG22 ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 56' ' ' LEU . 27.4 mt -114.64 117.54 31.14 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.476 -0.765 . . . . 0.0 109.682 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 31.6 p80 -101.16 124.18 46.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.422 -0.799 . . . . 0.0 109.419 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.4 mp -117.16 145.46 43.82 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.6 t -133.21 112.35 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.183 -0.948 . . . . 0.0 108.969 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.1 142.63 31.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.348 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -116.01 155.56 27.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 74' ' ' ARG . 25.3 mt -84.64 165.51 17.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.974 -1.079 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 73' ' ' LEU . 67.0 ttt180 59.56 151.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.571 -0.706 . . . . 0.0 109.626 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.22 161.09 34.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.529 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.284 0.564 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -158.14 73.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 ' CG2' HD13 ' A' ' 69' ' ' LEU . 96.7 mt -81.06 131.31 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.658 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.69 153.45 22.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.4 103.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.246 -0.909 . . . . 0.0 109.299 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -93.81 125.25 38.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 109.598 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 11' ' ' LYS . 82.1 p -89.34 167.93 12.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.154 -0.966 . . . . 0.0 109.476 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -69.58 -33.43 72.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.845 . . . . 0.0 109.378 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -78.69 0.6 25.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -18.25 56.33 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' THR . 99.4 mttt -56.76 112.49 1.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -1.162 . . . . 0.0 108.929 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -92.55 152.88 19.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.055 -1.028 . . . . 0.0 109.826 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.4 mt -142.94 139.2 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -107.2 124.51 49.83 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 tp -121.42 114.35 21.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -99.41 113.56 25.97 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 0.0 108.971 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.479 ' CG2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 p -158.1 147.76 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.371 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -48.83 150.64 2.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 109.244 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' HD12 ' A' ' 56' ' ' LEU . 72.8 Cg_endo -73.96 -24.73 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.276 1.984 . . . . 0.0 112.564 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -75.12 1.31 13.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.835 -1.165 . . . . 0.0 109.981 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -61.85 154.08 27.03 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -83.11 173.76 11.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.907 -1.12 . . . . 0.0 110.525 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.46 -49.83 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.528 -0.733 . . . . 0.0 109.486 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.8 -25.74 60.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.441 -0.787 . . . . 0.0 109.046 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' OD1' ' CE ' ' A' ' 29' ' ' LYS . 25.6 t-20 -67.31 -41.52 85.17 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -68.66 -61.12 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -45.49 -42.48 10.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.525 -0.734 . . . . 0.0 109.725 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.39 -57.5 5.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' CE ' ' OD1' ' A' ' 25' ' ' ASN . 35.5 mttm -45.42 -36.78 4.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.881 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 -43.59 42.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.799 -1.188 . . . . 0.0 108.842 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.9 tt0 -48.64 -48.76 39.35 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.513 -0.742 . . . . 0.0 109.579 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.65 -29.53 70.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.218 -0.926 . . . . 0.0 110.406 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -80.43 -44.24 19.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.005 -1.06 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -92.18 -32.15 15.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.972 -1.08 . . . . 0.0 109.786 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 86.66 12.56 69.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -93.63 135.68 24.88 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.589 -0.948 . . . . 0.0 109.102 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.31 121.13 6.95 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.565 1.51 . . . . 0.0 111.755 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' GLN . 29.1 Cg_exo -40.07 -27.29 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.627 2.218 . . . . 0.0 113.581 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.65 -43.74 93.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.893 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.88 -3.79 43.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 110.858 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 38' ' ' PRO . 35.1 mt-30 -133.67 136.58 44.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.102 -0.999 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.438 HH12 ' CD ' ' A' ' 74' ' ' ARG . 87.1 mtm-85 -132.1 138.12 47.99 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -87.26 142.62 27.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.857 -1.152 . . . . 0.0 110.546 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.8 135.66 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.618 ' CE1' ' CE1' ' A' ' 68' ' ' HIS . 72.8 t80 -126.41 102.98 7.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 0.0 109.275 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.26 54.56 8.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.024 . . . . 0.0 110.365 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.37 -3.45 8.01 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 121.104 -0.997 . . . . 0.0 111.485 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -87.86 160.36 18.01 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.652 -1.499 . . . . 0.0 109.792 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -122.96 125.75 45.87 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.366 0.603 . . . . 0.0 109.691 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -95.24 125.16 39.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.358 -0.839 . . . . 0.0 109.185 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -93.67 153.24 18.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.28 -0.887 . . . . 0.0 109.62 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.2 p30 -65.45 156.53 32.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.609 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.53 40.21 11.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -152.64 153.08 32.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -1.087 . . . . 0.0 110.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 56' ' ' LEU . 43.6 m -119.45 164.03 16.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.538 ' N ' HG22 ' A' ' 55' ' ' THR . 13.5 mt -66.78 -47.46 72.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 60' ' ' ASN . 75.8 m -58.25 -52.5 65.34 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -49.85 -30.76 10.5 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -17.83 60.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 108.727 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.77 62.15 2.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 109.978 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 64' ' ' GLU . 61.6 mt -61.18 131.29 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.16 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -69.98 -50.72 38.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 64' ' ' GLU . 33.3 mtmm -65.7 -31.77 72.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.992 -1.067 . . . . 0.0 110.037 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 63' ' ' LYS . 82.1 tt0 41.54 66.17 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -0.783 . . . . 0.0 110.258 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.2 mt -97.6 122.92 41.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 45' ' ' PHE . 44.7 p-80 -95.56 129.22 42.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.6 mp -120.54 138.4 53.88 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.74 116.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 71' ' ' LEU . 10.9 mp -82.56 142.36 31.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 0.0 109.782 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -111.5 154.83 24.17 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 mt -114.98 144.86 42.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.418 -0.801 . . . . 0.0 109.071 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' CD ' HH12 ' A' ' 42' ' ' ARG . 54.3 ttt85 -170.83 136.46 1.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.122 -0.986 . . . . 0.0 109.517 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.38 -176.0 47.75 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.509 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -80.95 86.7 6.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -77.43 136.46 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.005 . . . . 0.0 109.222 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -93.82 150.51 20.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.107 -0.996 . . . . 0.0 109.775 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.66 112.7 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -102.18 121.09 41.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.222 -0.924 . . . . 0.0 109.952 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 8' ' ' LEU . 40.3 m -82.89 163.57 21.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' N ' HG22 ' A' ' 7' ' ' THR . 57.0 tp -61.43 -34.15 74.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.8 p -78.75 2.17 20.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 91.35 -18.23 52.82 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -53.85 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 108.698 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' GLY . 96.0 m -94.83 124.83 39.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.236 -0.915 . . . . 0.0 109.931 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.72 155.78 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.0 p -110.14 128.47 55.48 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -124.16 120.01 31.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.537 -0.727 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -103.17 117.93 35.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.279 -0.888 . . . . 0.0 109.144 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.15 150.72 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.919 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 31.9 mp0 -48.83 110.39 1.48 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.542 -0.724 . . . . 0.0 109.622 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 56' ' ' LEU . 87.6 Cg_exo -46.37 -18.92 0.53 Allowed 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.048 1.832 . . . . 0.0 112.765 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 55' ' ' THR . 2.0 m -75.66 3.5 9.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.884 -1.135 . . . . 0.0 109.41 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -66.2 159.25 26.8 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.281 -0.887 . . . . 0.0 108.817 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -80.82 170.14 16.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.799 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -69.92 -38.13 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.322 -0.861 . . . . 0.0 108.805 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.76 -24.11 65.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 108.948 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 39.1 t30 -72.22 -44.06 63.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 28' ' ' ALA . 16.9 t -65.2 -63.86 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 26' ' ' VAL . 94.8 mttt -42.12 -25.88 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.369 0.604 . . . . 0.0 109.867 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.15 -57.06 8.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.85 -26.24 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.738 . . . . 0.0 109.559 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -83.07 -66.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 0.0 108.84 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 46.4 tt0 -39.01 -46.36 1.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.765 -0.584 . . . . 0.0 111.134 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -69.31 -53.98 16.91 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.989 -1.069 . . . . 0.0 110.396 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -60.05 -38.83 83.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.752 . . . . 0.0 110.777 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.1 -22.77 17.12 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.751 -1.218 . . . . 0.0 110.182 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 68.38 14.92 67.41 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mt -94.08 135.8 24.26 Favored Pre-proline 0 C--N 1.306 -1.31 0 O-C-N 121.428 -1.043 . . . . 0.0 109.554 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.31 130.57 10.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.92 1.747 . . . . 0.0 111.603 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 40' ' ' GLN . 24.7 Cg_exo -38.39 -43.76 1.95 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.378 2.052 . . . . 0.0 113.227 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.67 -7.9 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.849 . . . . 0.0 110.387 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 38' ' ' PRO . 16.6 mm100 -110.8 6.34 21.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.196 -0.94 . . . . 0.0 109.651 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -151.87 149.38 28.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.089 -1.007 . . . . 0.0 110.971 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -132.19 137.18 47.51 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 44' ' ' ILE . 13.9 mt -88.15 137.77 32.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.478 -1.389 . . . . 0.0 110.532 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.3 mp -117.01 132.67 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -145.44 103.29 3.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.066 -1.021 . . . . 0.0 109.041 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 62.7 35.4 14.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.326 -0.859 . . . . 0.0 111.269 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 2.69 90.59 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.496 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.64 147.84 48.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -1.076 . . . . 0.0 108.611 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -103.6 171.11 7.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.18 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.9 mt -109.31 135.63 50.07 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.345 -0.847 . . . . 0.0 109.212 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -93.84 159.16 15.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.226 -0.921 . . . . 0.0 109.561 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.5 148.25 33.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 74.35 -166.5 54.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 5.9 tpt180 72.03 157.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -1.212 . . . . 0.0 109.328 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 56' ' ' LEU . 85.1 m -120.13 165.6 14.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.561 -0.712 . . . . 0.0 109.221 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' N ' HG22 ' A' ' 55' ' ' THR . 15.4 mt -67.07 -42.9 83.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 0.0 109.014 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 60' ' ' ASN . 82.9 p -62.88 -46.86 85.88 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 49.7 t0 -51.02 -35.03 32.08 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -73.64 -16.89 61.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 108.803 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 57' ' ' SER . 13.9 t-20 58.28 61.36 2.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.405 -0.809 . . . . 0.0 109.806 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.85 132.29 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.163 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 27.0 mp0 -60.38 -50.04 75.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 109.644 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 64' ' ' GLU . 63.3 mttp -64.61 -24.74 67.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.091 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 63' ' ' LYS . 19.6 pt-20 37.32 43.42 0.37 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.599 -0.688 . . . . 0.0 110.792 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.24 152.71 28.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 0.0 109.74 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' C ' HD12 ' A' ' 69' ' ' LEU . 79.7 m80 -115.84 135.66 53.79 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.675 -0.641 . . . . 0.0 109.789 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -119.37 149.3 42.06 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -134.02 122.64 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.136 -0.977 . . . . 0.0 109.15 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 71' ' ' LEU . 6.5 mp -80.45 147.72 30.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 0.0 109.1 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -131.03 160.8 33.53 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.3 mp -93.19 134.15 35.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.915 -1.116 . . . . 0.0 109.12 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -59.6 -44.4 93.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.347 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 76' ' ' GLY . . . -163.21 -1.5 0.05 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 75' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.263 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.558 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.58 85.24 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 3' ' ' ILE . 20.5 tt -78.34 131.57 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.21 155.06 18.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.49 109.09 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.68 116.27 28.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.083 -1.01 . . . . 0.0 109.325 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -85.37 153.15 22.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.56 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.7 tp -55.43 -33.12 63.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.32 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.5 p -78.97 -4.47 50.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.856 . . . . 0.0 109.689 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.6 -18.09 58.07 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.93 111.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.159 -1.201 . . . . 0.0 108.915 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -92.53 140.36 29.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.893 . . . . 0.0 109.918 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mt -142.28 137.27 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 t -121.1 136.28 55.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.488 -0.758 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 33' ' ' LYS . 30.5 mt -120.62 115.05 22.63 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.643 -0.661 . . . . 0.0 109.249 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.16 112.28 24.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.031 -1.043 . . . . 0.0 109.446 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 p -161.82 152.3 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.345 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 34.0 mp0 -44.89 118.26 3.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.372 -0.83 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -42.3 -24.49 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.013 1.808 . . . . 0.0 112.568 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 m -75.81 12.41 1.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.028 -1.045 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -55.43 163.42 1.24 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.892 . . . . 0.0 109.161 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.1 p -100.12 142.98 30.86 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.279 -0.888 . . . . 0.0 109.247 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.546 HD12 ' O ' ' A' ' 51' ' ' GLU . 90.6 mt -48.7 -39.0 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.583 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.6 mm-40 -54.16 -36.57 63.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -65.05 -38.73 91.77 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.316 -0.865 . . . . 0.0 108.769 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.8 t -67.62 -63.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.505 -0.747 . . . . 0.0 109.055 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -42.57 -33.88 0.77 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.549 -0.72 . . . . 0.0 109.962 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.77 -57.39 5.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.47 -0.769 . . . . 0.0 109.898 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -54.1 -30.26 47.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.84 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.58 -65.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -40.27 -47.29 2.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.795 -0.566 . . . . 0.0 110.564 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.55 -53.9 12.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.283 -0.886 . . . . 0.0 110.681 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 15' ' ' LEU . 97.7 mttt -58.54 -39.77 81.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.118 -0.989 . . . . 0.0 110.787 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.62 -23.54 18.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.801 -1.187 . . . . 0.0 109.36 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.33 18.52 73.42 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -102.15 107.07 51.42 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 121.532 -0.981 . . . . 0.0 109.757 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.99 121.64 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.812 1.675 . . . . 0.0 111.977 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 41' ' ' GLN . 27.6 Cg_exo -39.65 -27.81 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.458 2.105 . . . . 0.0 113.11 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -57.09 -28.06 62.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -98.38 5.51 48.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 38' ' ' PRO . 28.0 mt-30 -143.34 144.79 32.23 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.528 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -133.25 138.8 46.62 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 43' ' ' LEU . 6.0 mp -87.48 138.4 31.51 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.96 -1.088 . . . . 0.0 109.875 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -121.72 132.71 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 45.4 t80 -150.59 103.04 3.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.876 -1.14 . . . . 0.0 109.23 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 69.56 25.28 5.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.73 . . . . 0.0 110.771 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.92 7.24 78.21 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.789 -1.195 . . . . 0.0 110.586 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.14 148.97 50.16 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.36 -1.082 . . . . 0.0 109.34 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -94.04 162.45 13.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.099 -1.001 . . . . 0.0 108.653 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -98.36 107.61 20.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.03 -1.044 . . . . 0.0 108.814 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' O ' HD12 ' A' ' 23' ' ' ILE . 10.5 mm-40 -93.39 152.74 18.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.1 -1.0 . . . . 0.0 110.29 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -69.99 156.64 38.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.36 25.06 31.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -150.01 150.27 31.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.187 -1.184 . . . . 0.0 110.065 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 56' ' ' LEU . 53.1 m -109.82 168.02 9.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.569 ' N ' HG22 ' A' ' 55' ' ' THR . 16.2 mt -68.35 -42.55 79.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.077 . . . . 0.0 109.472 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 55' ' ' THR . 47.1 t -61.94 -50.62 71.4 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -48.32 -36.26 13.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.713 -0.617 . . . . 0.0 109.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -73.68 -17.55 61.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.995 . . . . 0.0 108.939 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 57' ' ' SER . 81.2 m-20 50.18 62.45 2.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 67' ' ' LEU . 13.6 pt -60.47 146.22 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.93 43.99 1.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.506 -0.746 . . . . 0.0 109.431 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' SEP . 30.6 mmtp -103.13 -1.05 29.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.436 -0.79 . . . . 0.0 109.268 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 62.9 -70.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.595 -0.691 . . . . 0.0 109.551 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.462 ' CG2' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 61' ' ' ILE . 28.4 mt -89.81 117.62 28.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.277 -0.889 . . . . 0.0 109.618 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' NE2' ' CG2' ' A' ' 66' ' ' TPO . 4.1 m-70 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.591 -0.693 . . . . 0.0 109.571 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.5 mp -118.4 162.71 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.6 121.17 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.091 -1.006 . . . . 0.0 109.351 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 mt -81.41 151.7 27.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 109.529 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -121.13 153.56 37.34 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 mt -100.41 166.02 11.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.152 -0.967 . . . . 0.0 109.365 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -61.21 -28.58 69.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.99 -173.88 46.55 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.991 -1.45 . . . . 0.0 109.586 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 49.9 60.65 3.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.675 ' CG2' HD13 ' A' ' 69' ' ' LEU . 15.9 mt -89.94 126.55 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.166 -0.959 . . . . 0.0 109.503 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.5 158.53 16.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.7 t -140.0 102.65 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.394 -0.816 . . . . 0.0 108.944 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 70' ' ' VAL . 67.9 mttm -98.13 127.6 44.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -92.94 167.52 11.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.55 -26.45 63.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.06 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.6 p -79.26 2.3 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.63 -18.08 48.71 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -61.76 94.63 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.221 -1.164 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -102.51 124.88 48.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.516 -0.74 . . . . 0.0 109.256 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 14' ' ' THR . 96.8 mt -107.01 155.15 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 108.781 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.4 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.0 m -99.68 116.28 31.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.874 . . . . 0.0 108.775 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 tp -116.43 114.44 24.25 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.457 -0.777 . . . . 0.0 108.95 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -106.15 120.58 42.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.318 -0.863 . . . . 0.0 109.375 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.43 147.84 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.454 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.19 150.87 91.67 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.548 -0.72 . . . . 0.0 109.47 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.9 -17.42 32.41 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.258 1.972 . . . . 0.0 111.81 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' THR . 16.0 p -75.61 -2.78 30.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.25 159.94 33.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 m -84.56 169.49 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.828 -1.17 . . . . 0.0 109.015 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -75.6 -48.87 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.87 -1.144 . . . . 0.0 108.162 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 3.1 pt-20 -56.33 -23.13 35.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.365 -0.834 . . . . 0.0 109.158 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 55.1 t-20 -71.13 -51.22 26.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' ALA . 44.3 t -53.75 -63.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' VAL . 67.3 mttm -39.27 -29.21 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.307 0.575 . . . . 0.0 109.974 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.9 -58.61 4.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.571 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 2.4 mppt? -53.96 -27.5 31.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.46 -66.06 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 35' ' ' GLY . 32.8 tt0 -39.87 -45.13 1.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.767 -0.583 . . . . 0.0 111.135 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.5 -54.45 12.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.058 -1.026 . . . . 0.0 110.36 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 33' ' ' LYS . 9.0 mptt -59.36 -39.32 82.9 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.279 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.18 -20.31 20.59 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.755 -1.216 . . . . 0.0 109.559 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 67.46 11.4 59.53 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.51 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 70.5 mt -88.3 115.05 62.1 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.377 -1.072 . . . . 0.0 109.762 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.0 156.25 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.702 1.601 . . . . 0.0 111.587 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.13 -16.76 19.76 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.803 2.336 . . . . 0.0 112.725 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -86.99 -14.71 40.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.197 -0.939 . . . . 0.0 109.888 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.98 7.5 46.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.935 . . . . 0.0 109.819 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 11.0 pt20 -139.58 140.52 37.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' NH1' ' OE1' ' A' ' 49' ' ' GLN . 12.0 mmm180 -131.52 127.98 38.38 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -88.31 144.47 26.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.828 -1.17 . . . . 0.0 110.753 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.4 mm -122.5 134.47 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -145.09 105.14 4.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.964 -1.085 . . . . 0.0 109.618 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . . . 60.83 27.52 17.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.483 -0.76 . . . . 0.0 111.19 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 2.57 73.85 Favored Glycine 0 N--CA 1.496 2.698 0 O-C-N 120.697 -1.252 . . . . 0.0 110.635 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -129.48 151.22 50.34 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.202 -1.176 . . . . 0.0 109.086 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' OE1' ' NH1' ' A' ' 42' ' ' ARG . 40.2 mt-30 -100.5 167.47 10.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.148 -0.97 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.2 mt -104.55 130.94 52.45 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.297 -0.877 . . . . 0.0 109.209 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.67 159.08 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.094 -1.004 . . . . 0.0 109.561 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.61 156.22 35.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 109.591 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.72 179.01 52.76 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 53' ' ' GLY . 98.0 mtt180 55.13 160.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.621 -0.929 . . . . 0.0 110.021 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.515 HG21 ' O ' ' A' ' 20' ' ' SER . 72.1 p -121.81 164.08 18.08 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.376 -0.827 . . . . 0.0 109.433 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -60.01 -46.62 88.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.262 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.4 t -61.74 -51.94 66.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.831 -1.168 . . . . 0.0 108.086 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 55' ' ' THR . 94.9 m-20 -49.08 -33.14 10.99 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.771 -0.58 . . . . 0.0 109.711 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -73.79 -21.16 60.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.77 -1.206 . . . . 0.0 109.262 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m120 64.14 53.81 1.74 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -85.35 150.3 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.317 -0.865 . . . . 0.0 109.805 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -153.09 75.24 1.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.416 -0.802 . . . . 0.0 109.086 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HZ3' ' HB2' ' A' ' 46' ' ' ALA . 88.5 tttt -108.47 -30.3 8.35 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.718 . . . . 0.0 109.91 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -174.57 158.57 2.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.1 mp -89.48 123.97 34.08 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.133 -0.979 . . . . 0.0 109.598 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.704 ' C ' HD12 ' A' ' 69' ' ' LEU . 24.9 p80 -106.57 134.63 49.41 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.703 . . . . 0.0 109.14 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.0 mp -129.81 152.02 49.75 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.6 p -136.19 121.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -82.73 146.34 29.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.0 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -119.03 157.36 27.94 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.8 mt -89.76 143.76 26.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.969 -1.082 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 49.34 -153.7 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.22 -161.3 31.96 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -167.36 57.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.882 . . . . 0.0 109.557 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.34 131.13 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -94.9 150.08 20.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.81 115.02 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.429 -0.794 . . . . 0.0 109.015 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -102.73 122.6 44.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.1 p -84.11 170.76 13.51 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.265 -0.897 . . . . 0.0 109.444 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.58 -33.8 76.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.267 -0.896 . . . . 0.0 109.271 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.0 p -78.58 0.6 25.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.723 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 12' ' ' THR . . . 92.0 -18.14 54.59 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.442 ' O ' HG23 ' A' ' 7' ' ' THR . 86.7 tttt -54.16 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.15 -1.206 . . . . 0.0 108.851 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 10' ' ' GLY . 95.6 m -96.45 126.8 41.9 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.318 -0.864 . . . . 0.0 109.747 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 pt -118.31 155.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 108.994 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -109.74 127.92 54.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.459 -0.776 . . . . 0.0 109.14 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -120.75 115.6 23.62 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.607 -0.683 . . . . 0.0 109.328 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 17' ' ' VAL . 53.8 mt-10 -97.79 114.59 26.66 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.229 -0.92 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 16' ' ' GLU . 16.5 m -157.19 147.8 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.361 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 94.5 mt-10 -43.32 113.88 1.52 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 109.904 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.7 -17.4 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.057 1.838 . . . . 0.0 112.789 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 18' ' ' GLU . 5.0 p -79.95 18.4 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.581 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 18' ' ' GLU . 1.2 m-20 -70.12 149.7 47.3 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.159 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -84.84 147.93 26.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.822 . . . . 0.0 109.355 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -47.82 -50.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -47.06 -33.63 5.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.15 -0.969 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.711 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 18.3 t-20 -66.15 -42.66 88.73 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' ALA . 25.7 t -59.35 -63.18 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 26' ' ' VAL . 99.3 mttt -39.25 -29.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.449 0.642 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -69.52 -57.51 5.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.818 . . . . 0.0 109.921 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.711 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 14.0 mptt -52.79 -32.41 43.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 mm -77.12 -65.47 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.918 -1.114 . . . . 0.0 108.853 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.6 tt0 -41.99 -48.07 4.5 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.81 -0.556 . . . . 0.0 110.997 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.57 -54.61 9.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.12 -0.987 . . . . 0.0 110.823 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.7 mmmm -58.2 -42.31 85.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 110.614 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -90.31 -21.21 22.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.791 -1.193 . . . . 0.0 109.469 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 71.02 11.73 70.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.84 136.24 23.08 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.662 -0.905 . . . . 0.0 109.317 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.57 126.53 10.3 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.855 1.703 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.1 Cg_exo -38.32 -38.89 0.93 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.49 2.127 . . . . 0.0 113.132 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -48.21 -45.18 33.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.856 . . . . 0.0 110.069 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.14 7.32 19.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.841 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 38' ' ' PRO . 77.8 mt-30 -134.33 142.21 47.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.398 -0.813 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -133.61 130.96 39.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.52 144.58 26.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 110.298 -179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.02 134.4 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.215 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -150.7 120.31 6.97 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.954 -1.091 . . . . 0.0 109.306 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.31 29.99 7.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.381 -0.824 . . . . 0.0 110.747 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 4.88 90.3 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.271 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -125.53 149.02 48.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.367 -1.078 . . . . 0.0 108.875 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -100.14 167.11 10.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.288 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 mt -108.33 126.73 53.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.428 -0.795 . . . . 0.0 108.859 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -93.48 158.97 15.45 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.1 -1.0 . . . . 0.0 109.628 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -61.4 153.62 26.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 81.6 -176.96 54.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' GLY . 99.0 mtt180 56.3 156.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.775 -0.838 . . . . 0.0 110.196 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -120.67 176.12 5.68 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.335 -0.853 . . . . 0.0 108.722 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -59.64 -39.92 85.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.064 -1.022 . . . . 0.0 108.668 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.1 m -62.93 -47.34 83.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -52.89 -37.4 60.51 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 43.1 m-85 -76.84 -8.57 57.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.248 -0.907 . . . . 0.0 109.268 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TYR . 37.4 t30 74.21 37.61 0.59 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 110.082 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -92.14 126.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.193 -0.942 . . . . 0.0 109.059 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -150.95 -48.88 0.12 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.013 -1.054 . . . . 0.0 109.71 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -65.03 -7.19 10.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -0.996 . . . . 0.0 109.38 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 65' ' ' SEP . 74.4 mm-40 -87.75 70.98 9.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -78.64 117.79 20.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -128.77 135.25 48.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 109.359 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -125.36 159.06 32.7 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 70' ' ' VAL . 5.2 m -135.47 124.76 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.157 -0.965 . . . . 0.0 108.965 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.6 mm? -82.53 148.15 28.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.321 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -120.83 164.51 16.52 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.8 mt -112.37 140.23 47.27 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.184 -0.948 . . . . 0.0 109.134 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -159.49 146.45 16.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.94 3.71 90.5 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.536 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -159.34 67.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.86 148.33 25.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.358 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.65 107.48 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.297 -0.877 . . . . 0.0 109.255 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -95.23 121.71 37.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.925 -1.109 . . . . 0.0 109.573 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 11' ' ' LYS . 71.6 p -84.46 167.62 16.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.525 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.23 -35.95 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 9' ' ' THR . 56.3 m -78.46 -0.54 29.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.12 -18.34 57.0 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 7' ' ' THR . 12.9 ttmm -52.15 103.27 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -92.71 150.2 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.321 -0.862 . . . . 0.0 110.033 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 pt -146.53 149.38 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 p -124.32 137.36 54.49 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.396 -0.815 . . . . 0.0 109.38 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.0 mt -120.39 114.98 22.63 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 17' ' ' VAL . 63.3 mt-10 -90.88 112.58 24.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.114 -0.991 . . . . 0.0 109.629 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 16' ' ' GLU . 17.5 m -158.06 148.26 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.435 -0.791 . . . . 0.0 108.91 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 93.0 mt-10 -41.37 150.84 0.31 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.422 -0.799 . . . . 0.0 109.786 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 21' ' ' ASP . 47.2 Cg_endo -67.24 -28.95 39.66 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.242 1.961 . . . . 0.0 112.532 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 21' ' ' ASP . 2.6 p -75.14 19.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.711 -1.243 . . . . 0.0 109.587 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -53.44 -173.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.322 -0.861 . . . . 0.0 109.176 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.488 ' OG1' ' ND2' ' A' ' 25' ' ' ASN . 59.0 p -137.49 144.39 42.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.417 -0.802 . . . . 0.0 109.287 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -50.21 -16.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.447 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 4.5 mm-40 -85.06 -36.08 21.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 22' ' ' THR . 42.6 m-80 -72.33 -34.67 68.23 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.268 -0.895 . . . . 0.0 108.911 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.4 t -74.59 -63.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.45 -0.781 . . . . 0.0 109.177 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -47.81 -34.89 9.27 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.256 -0.903 . . . . 0.0 109.965 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -68.69 -57.77 5.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.116 -0.99 . . . . 0.0 109.225 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -54.92 -29.06 55.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 31' ' ' GLN . 79.1 mt -78.99 -63.32 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.991 -1.068 . . . . 0.0 108.859 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -37.31 -40.99 0.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.152 0.501 . . . . 0.0 110.632 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 10.2 m-20 -67.45 -54.65 18.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.043 -1.036 . . . . 0.0 109.677 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -59.33 -41.83 90.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 110.874 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -90.06 -26.88 20.05 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.656 -1.277 . . . . 0.0 109.867 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 69.57 12.1 66.38 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.1 mt -89.63 128.31 51.14 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.454 -1.027 . . . . 0.0 109.719 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 39' ' ' ASP . 95.2 Cg_endo -78.53 128.39 8.7 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.853 1.702 . . . . 0.0 111.707 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' GLN . 22.5 Cg_exo -38.1 -27.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.495 2.13 . . . . 0.0 113.163 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.6 m-20 -60.54 -41.64 94.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.183 -0.948 . . . . 0.0 109.857 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -93.2 -0.57 56.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' PRO . 3.7 tt0 -127.44 138.07 52.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 mmt85 -132.11 126.62 34.18 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -88.65 142.83 27.36 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.722 -1.236 . . . . 0.0 110.872 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.5 mm -125.39 133.96 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -146.33 111.17 5.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.509 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.77 26.59 13.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.394 -0.816 . . . . 0.0 111.035 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.58 4.11 80.3 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.66 -1.275 . . . . 0.0 110.293 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -129.14 151.1 50.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.273 -1.134 . . . . 0.0 108.85 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -97.12 166.17 11.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.934 -1.103 . . . . 0.0 109.2 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -99.45 114.14 26.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.189 -0.944 . . . . 0.0 109.157 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -93.37 159.11 15.4 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.0 109.663 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 83.5 m-20 -72.6 156.21 39.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.682 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.69 49.42 5.13 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' CD ' ' CD1' ' A' ' 59' ' ' TYR . 37.7 ttm180 -159.01 144.96 16.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 109.863 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 57' ' ' SER . 18.7 m -123.71 151.17 43.46 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 55' ' ' THR . 10.8 mp -42.0 -41.34 2.49 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.776 -1.202 . . . . 0.0 110.26 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 55' ' ' THR . 48.3 t -55.64 -55.65 29.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.749 -1.219 . . . . 0.0 107.992 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -59.97 -32.67 71.04 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CD1' ' CD ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -73.71 2.92 7.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 m120 50.32 63.51 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.506 -0.746 . . . . 0.0 111.127 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.2 pt -59.68 139.33 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 108.578 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.94 -67.12 0.95 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.279 -0.888 . . . . 0.0 110.783 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' C ' ' H ' ' A' ' 65' ' ' SEP . 69.0 mttm -80.48 -31.4 37.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.543 -178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 46.45 15.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 109.549 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.615 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -67.2 119.54 12.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.333 -0.854 . . . . 0.0 109.348 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.56 ' C ' HD12 ' A' ' 69' ' ' LEU . 35.0 p80 -116.13 133.33 56.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.523 -0.735 . . . . 0.0 109.179 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 68' ' ' HIS . 10.7 mp -124.4 156.92 36.28 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.48 122.71 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.934 -1.104 . . . . 0.0 109.219 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.1 mp -81.43 148.09 29.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 109.002 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -126.85 152.99 46.26 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.3 mp -97.68 125.92 42.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 0.0 109.299 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 46.77 63.17 2.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 109.68 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.19 95.32 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.498 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -159.37 83.5 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.1 mp -71.44 127.52 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -81.67 144.83 30.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 109.667 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.23 102.38 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -103.55 136.43 43.29 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.245 -0.909 . . . . 0.0 109.507 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -96.95 -175.9 3.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.269 -0.894 . . . . 0.0 109.341 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.03 -30.02 43.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.623 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 9' ' ' THR . 46.1 m -79.02 -2.24 39.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -17.49 59.13 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -52.63 109.65 0.42 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.23 -1.159 . . . . 0.0 108.919 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.2 m -92.6 147.37 22.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.129 -0.982 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -142.83 140.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.4 p -126.12 135.78 52.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.265 -0.897 . . . . 0.0 109.255 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.6 mt -118.1 114.89 23.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -90.75 112.61 24.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 109.49 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG21 ' OD2' ' A' ' 21' ' ' ASP . 4.8 p -162.38 154.53 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.049 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' N ' HG22 ' A' ' 17' ' ' VAL . 62.1 mm-40 -45.38 150.51 0.84 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -12.36 33.53 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.199 1.933 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 55' ' ' THR . 3.4 m -87.37 13.21 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 17' ' ' VAL . 9.9 t70 -48.09 162.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 m -111.42 140.53 45.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.117 -0.99 . . . . 0.0 109.734 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -47.89 -55.93 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.433 -0.792 . . . . 0.0 109.684 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.84 -33.83 51.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -69.03 -44.38 72.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.032 -1.043 . . . . 0.0 109.03 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.04 -63.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -43.42 -33.11 0.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.734 -0.604 . . . . 0.0 109.74 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.61 -57.48 5.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.502 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -52.67 -28.2 20.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 109.698 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 31' ' ' GLN . 78.5 mt -83.11 -62.55 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 30' ' ' ILE . 8.4 tt0 -38.62 -45.32 1.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.646 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -71.25 -54.16 11.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.338 -0.851 . . . . 0.0 110.303 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -58.8 -45.4 89.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -84.27 -28.31 27.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.688 -1.258 . . . . 0.0 109.019 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.0 4.37 88.69 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.83 134.34 37.51 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.544 -0.974 . . . . 0.0 108.925 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.8 Cg_endo -76.0 121.59 6.28 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.668 1.579 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -39.59 -20.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 122.24 1.96 . . . . 0.0 112.599 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' PRO . 18.4 t70 -61.65 -44.8 96.29 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 109.885 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -87.27 12.51 11.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.455 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -131.85 141.9 49.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.175 -0.953 . . . . 0.0 109.997 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.677 HH11 HH22 ' A' ' 74' ' ' ARG . 18.2 mmt180 -133.13 128.08 35.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -88.53 147.44 24.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.694 -1.254 . . . . 0.0 110.412 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.7 mm -125.26 133.65 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -147.49 119.37 8.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 109.91 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 21.16 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.335 -0.853 . . . . 0.0 111.398 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.24 -0.03 68.29 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 120.478 -1.389 . . . . 0.0 109.995 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -126.83 151.31 48.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.44 -1.035 . . . . 0.0 108.882 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -91.54 166.98 12.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.017 -1.052 . . . . 0.0 109.366 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 mt -98.3 129.6 45.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.232 -0.917 . . . . 0.0 108.847 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' OE1' ' NH1' ' A' ' 54' ' ' ARG . 89.5 mt-10 -93.36 145.72 24.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.83 149.58 26.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.374 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 88.56 178.66 46.63 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 51' ' ' GLU . 83.7 mtm180 53.98 163.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.789 -0.83 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 66.4 p -120.24 168.79 10.88 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.359 -0.838 . . . . 0.0 109.364 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.78 -41.94 92.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -66.88 -45.2 78.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.024 -1.047 . . . . 0.0 108.269 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 55' ' ' THR . 52.2 t0 -54.8 -34.49 62.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -73.47 -21.09 60.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.819 -1.175 . . . . 0.0 109.34 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 63.24 44.24 5.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -72.59 150.38 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.424 -0.797 . . . . 0.0 109.423 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -149.81 70.25 1.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.176 -0.952 . . . . 0.0 109.729 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -108.24 -29.74 8.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 65' ' ' SEP . 88.3 tt0 -172.32 153.99 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.418 ' C ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.48 119.82 31.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.502 ' C ' HD12 ' A' ' 69' ' ' LEU . 20.1 p-80 -105.14 126.94 52.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.503 -0.748 . . . . 0.0 109.49 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.0 mp -124.43 148.47 47.6 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.72 126.1 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.816 -1.177 . . . . 0.0 109.357 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp -81.24 143.9 31.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 0.0 109.705 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -118.95 163.53 16.8 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.02 160.5 14.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.032 -1.042 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.677 HH22 HH11 ' A' ' 42' ' ' ARG . 66.1 ttt180 -152.37 122.2 6.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.336 -0.853 . . . . 0.0 109.271 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.77 101.86 0.25 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.565 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -83.19 80.82 8.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -86.21 132.14 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.218 -0.926 . . . . 0.0 109.42 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.6 158.26 15.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.501 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.46 107.38 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.245 -0.909 . . . . 0.0 108.904 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -102.86 127.11 50.18 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.343 -0.848 . . . . 0.0 110.049 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.9 p -92.06 -178.08 4.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.259 -0.901 . . . . 0.0 109.096 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.0 mt -78.99 -27.09 43.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.036 -1.04 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.1 p -79.87 3.05 20.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.22 63.78 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -61.62 94.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -1.076 . . . . 0.0 109.165 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -102.41 124.9 48.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.443 -0.786 . . . . 0.0 109.592 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' THR . 96.2 mt -113.98 155.54 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 13' ' ' ILE . 97.5 m -107.59 125.49 51.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.106 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.8 mt -122.14 117.98 27.55 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.494 -0.754 . . . . 0.0 109.143 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -95.17 112.4 24.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.408 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.67 147.83 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.176 -0.952 . . . . 0.0 109.2 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.03 149.64 9.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 109.561 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.43 -20.56 12.32 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.437 2.091 . . . . 0.0 112.602 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 55' ' ' THR . 1.8 m -75.16 -5.7 45.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 0.0 109.808 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.07 154.54 9.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.209 -0.932 . . . . 0.0 108.598 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -82.14 143.47 31.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.844 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.4 mp -46.9 -52.11 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.0 109.772 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -47.24 -31.64 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 66.2 t30 -66.45 -41.37 89.2 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' ALA . 24.5 t -60.97 -63.14 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 52.1 mttp -38.85 -28.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.424 0.631 . . . . 0.0 109.98 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.04 -57.79 6.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.82 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 13.3 mptt -50.05 -30.72 11.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 108.799 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -75.79 -65.53 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 O-C-N 120.847 -1.158 . . . . 0.0 107.915 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -45.69 -50.65 13.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.722 -0.611 . . . . 0.0 110.955 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 50.7 t0 -67.1 -20.69 65.83 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.027 -1.046 . . . . 0.0 112.475 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 5.0 mmmm -99.95 -44.83 5.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.741 -1.225 . . . . 0.0 110.55 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.99 -23.21 28.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.109 . . . . 0.0 109.086 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.06 14.26 73.45 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mt -92.38 135.56 26.58 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.579 -0.953 . . . . 0.0 108.979 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.81 121.72 6.83 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.796 1.664 . . . . 0.0 111.717 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 41' ' ' GLN . 28.4 Cg_exo -39.72 -34.25 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.349 2.033 . . . . 0.0 113.146 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.9 t0 -54.14 -22.78 12.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.749 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -102.5 0.99 34.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' PRO . 31.8 mt-30 -140.06 143.06 36.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.544 HH11 ' C ' ' A' ' 75' ' ' GLY . 16.6 mtt180 -133.05 138.26 46.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.6 mp -87.52 141.18 28.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 110.154 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.9 mm -128.07 137.26 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -127.51 106.86 9.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.327 -0.858 . . . . 0.0 108.93 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.82 50.05 19.07 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.731 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.04 -0.3 3.58 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -88.36 146.01 25.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.816 -1.402 . . . . 0.0 110.345 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -104.03 131.55 51.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.14 142.1 42.11 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -93.43 154.93 17.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.035 -1.041 . . . . 0.0 109.491 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -57.32 156.09 8.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 23' ' ' ILE . . . 77.89 -176.52 53.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.554 ' O ' HD12 ' A' ' 23' ' ' ILE . 27.5 ttm180 64.04 162.91 0.12 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -1.015 . . . . 0.0 109.945 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 63.3 p -119.82 176.61 5.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.58 -0.7 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.3 mp -68.98 -44.42 72.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.196 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 60' ' ' ASN . 83.1 p -60.64 -51.21 70.36 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 55' ' ' THR . 86.1 m-20 -50.99 -32.26 20.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' O ' ' CB ' ' A' ' 60' ' ' ASN . 4.2 m-85 -73.7 -16.77 61.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.076 -1.015 . . . . 0.0 108.446 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 57' ' ' SER . 1.7 m120 73.74 62.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.715 -0.615 . . . . 0.0 110.009 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' H ' ' A' ' 64' ' ' GLU . 6.2 tp -67.17 150.31 11.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.207 -0.933 . . . . 0.0 108.61 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -88.16 -51.03 6.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.713 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 64' ' ' GLU . 61.8 tttp -65.42 -32.02 73.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.943 -1.098 . . . . 0.0 110.292 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' HG13 ' A' ' 61' ' ' ILE . 77.6 tt0 41.87 61.87 1.77 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.332 -0.855 . . . . 0.0 110.418 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.29 148.07 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.852 . . . . 0.0 109.768 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -113.1 136.95 52.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.699 -0.625 . . . . 0.0 109.503 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.31 152.13 36.36 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.7 t -138.12 121.21 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.7 mp -81.76 148.15 29.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CD ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -113.09 161.59 16.91 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 6.9 tp -104.45 158.39 16.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.881 -1.137 . . . . 0.0 109.193 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 73' ' ' LEU . 55.8 ttm-85 59.86 150.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 109.769 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' C ' HH11 ' A' ' 42' ' ' ARG . . . 159.49 53.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.615 179.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.428 ' H ' ' HA ' ' A' ' 16' ' ' GLU . 7.7 tt0 52.15 62.86 2.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.489 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 82.0 mt -72.61 135.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE1' ' O1P' ' A' ' 66' ' ' TPO . 83.2 m-85 -85.96 148.89 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.3 t -142.82 107.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -0.84 . . . . 0.0 108.96 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -107.34 132.65 52.91 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -101.96 172.74 6.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.436 -0.79 . . . . 0.0 108.965 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.27 -16.25 61.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 109.319 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 p -88.49 -0.56 57.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 -9.91 73.83 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.38 109.46 1.01 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.327 -1.102 . . . . 0.0 109.161 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -94.9 140.35 30.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 109.622 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.62 138.39 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.6 p -120.98 136.87 54.87 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.39 -0.819 . . . . 0.0 109.291 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -121.21 114.13 20.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.579 -0.701 . . . . 0.0 109.127 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 88.3 tt0 -98.46 116.21 30.2 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.106 -0.996 . . . . 0.0 109.127 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 p -163.15 153.67 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.15 -0.969 . . . . 0.0 109.781 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.05 111.6 1.33 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.428 -0.795 . . . . 0.0 109.631 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.49 -20.58 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.165 1.91 . . . . 0.0 112.957 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 55' ' ' THR . 14.3 p -75.51 -3.8 36.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.974 -1.079 . . . . 0.0 109.476 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.87 154.32 5.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 108.77 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -86.3 145.85 26.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.246 -0.909 . . . . 0.0 110.045 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.636 ' CG2' ' HZ3' ' A' ' 27' ' ' LYS . 97.3 mt -45.2 -29.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 109.455 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 4.8 mm-40 -63.09 -34.45 77.62 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.62 -0.675 . . . . 0.0 109.245 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.08 -40.33 86.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.2 t -66.48 -64.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.636 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 54.8 mttp -45.11 -35.18 2.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.16 -57.63 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 109.889 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -53.52 -26.77 22.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.19 -0.944 . . . . 0.0 109.672 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.536 HG21 HE22 ' A' ' 41' ' ' GLN . 79.4 mt -84.73 -64.86 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.8 tt0 -40.14 -45.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.565 -0.709 . . . . 0.0 110.912 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -69.81 -53.84 16.37 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.206 -0.934 . . . . 0.0 110.094 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -58.91 -38.56 79.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.714 . . . . 0.0 110.413 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -95.17 -22.61 17.73 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.772 -1.205 . . . . 0.0 109.717 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 65.53 25.73 71.6 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mt -105.12 104.28 46.29 Favored Pre-proline 0 N--CA 1.486 1.345 0 O-C-N 121.301 -1.117 . . . . 0.0 109.915 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 39' ' ' ASP . 80.0 Cg_exo -48.99 122.27 8.06 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.852 1.701 . . . . 0.0 111.808 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLN . 26.4 Cg_exo -39.08 -20.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.422 2.082 . . . . 0.0 113.004 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 37' ' ' PRO . 8.4 m-20 -63.28 -45.15 92.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 109.909 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.5 -2.94 58.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.029 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.536 HE22 HG21 ' A' ' 30' ' ' ILE . 28.5 tt0 -120.69 137.27 54.56 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -133.46 116.82 16.46 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -88.57 140.87 29.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.763 -1.211 . . . . 0.0 109.992 -179.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.98 141.11 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 33.7 t80 -150.41 109.01 3.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.067 -1.021 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 63.42 22.19 13.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.473 -0.767 . . . . 0.0 110.92 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.9 79.21 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -128.64 149.69 50.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.429 -1.042 . . . . 0.0 109.156 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -97.43 163.7 12.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.06 -1.025 . . . . 0.0 108.707 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 mt -99.04 109.85 22.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.109 -0.994 . . . . 0.0 108.347 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.5 mm-40 -93.02 149.21 21.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.105 -0.997 . . . . 0.0 110.142 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 21.5 m-20 -66.45 156.37 34.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.738 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.12 42.26 5.65 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.95 154.86 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -1.203 . . . . 0.0 109.865 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 56' ' ' LEU . 40.0 m -114.19 169.54 8.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.612 ' N ' HG22 ' A' ' 55' ' ' THR . 16.8 mt -69.72 -48.18 60.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.93 -1.106 . . . . 0.0 109.049 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 60' ' ' ASN . 74.5 m -61.73 -50.82 70.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 67.2 t0 -50.49 -33.25 20.62 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -17.26 61.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 108.555 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 57' ' ' SER . 64.8 t30 57.5 62.04 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.415 -0.803 . . . . 0.0 109.462 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.01 150.24 6.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.287 -0.883 . . . . 0.0 109.874 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -136.02 40.37 2.71 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.494 -0.754 . . . . 0.0 109.083 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -88.74 -26.31 21.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.379 -0.826 . . . . 0.0 109.239 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 52.7 46.37 26.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.44 ' O1P' ' CE1' ' A' ' 4' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.0 117.38 23.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -119.66 134.48 55.21 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 mt -120.89 158.4 27.73 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 70' ' ' VAL . 12.6 m -139.42 123.96 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.047 -1.033 . . . . 0.0 109.183 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -84.01 148.42 26.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -119.0 164.99 14.65 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.0 mt -113.94 143.54 44.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -146.68 130.51 17.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 13.16 83.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' VAL . 28.2 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 50.83 52.86 14.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.451 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.63 132.04 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -83.87 142.54 30.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.396 -0.815 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.85 104.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.395 -0.815 . . . . 0.0 108.922 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -98.61 130.08 45.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.145 -0.972 . . . . 0.0 109.953 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -94.49 174.79 6.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' H ' ' A' ' 73' ' ' LEU . 75.5 mt -68.36 -32.62 72.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.38 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -79.15 -0.93 33.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.614 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 -16.08 58.96 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -47.45 120.34 3.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -1.132 . . . . 0.0 109.347 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -92.76 140.78 29.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.153 -0.967 . . . . 0.0 109.706 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 36.5 mt -142.44 139.36 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -123.21 139.01 54.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.68 115.57 19.65 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.81 111.63 23.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.118 -0.989 . . . . 0.0 109.673 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 1' ' ' MET . 4.3 p -160.81 151.41 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.441 -0.787 . . . . 0.0 109.348 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' SER . 3.5 pt-20 -48.16 121.75 9.25 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.323 -0.861 . . . . 0.0 109.342 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 21' ' ' ASP . 97.8 Cg_exo -42.22 -15.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.904 1.736 . . . . 0.0 112.398 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' GLU . 9.9 p -75.53 11.86 1.17 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.139 -0.976 . . . . 0.0 109.141 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -50.09 170.7 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.442 -0.786 . . . . 0.0 109.131 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -121.66 148.2 44.88 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.489 0.662 . . . . 0.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 mp -49.74 -49.64 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.895 . . . . 0.0 108.93 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.06 -34.05 75.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.408 -0.807 . . . . 0.0 110.009 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -70.25 -44.55 68.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.1 -1.0 . . . . 0.0 109.191 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.95 -62.11 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -44.36 -44.63 8.37 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.738 -0.602 . . . . 0.0 109.678 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -57.1 7.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mttp -44.55 -37.21 3.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 110.123 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.4 -40.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.687 -1.258 . . . . 0.0 108.817 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.8 tt0 -50.4 -52.18 39.75 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.502 -0.749 . . . . 0.0 110.366 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.25 -29.35 68.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.0 110.784 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 6.9 mptt -77.75 -45.16 25.44 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.222 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE2' ' CD1' ' A' ' 13' ' ' ILE . 64.4 mt-10 -96.35 -32.57 12.31 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.027 -1.045 . . . . 0.0 110.215 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 87.42 17.75 58.24 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -98.16 109.77 53.34 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 121.581 -0.952 . . . . 0.0 109.562 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.38 120.88 4.11 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.933 1.756 . . . . 0.0 112.409 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -41.4 -39.32 4.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.571 2.181 . . . . 0.0 113.399 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.524 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 6.9 m-20 -54.78 -30.32 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.558 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -87.65 3.86 46.15 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 109.899 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -135.99 138.39 42.21 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.236 -0.915 . . . . 0.0 110.322 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -132.21 130.07 40.53 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.2 mp -88.56 144.62 26.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.906 -1.121 . . . . 0.0 110.644 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.08 136.03 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -129.87 106.33 8.6 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.301 -0.874 . . . . 0.0 109.834 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.94 51.46 12.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.39 -0.819 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.07 -4.05 4.95 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.943 -1.123 . . . . 0.0 110.625 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -89.71 167.14 13.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.935 -1.332 . . . . 0.0 109.827 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -130.34 128.11 40.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.27 131.62 41.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.64 155.86 17.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.268 -0.895 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.2 156.04 39.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.298 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.51 37.11 12.53 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -156.85 155.55 31.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -1.128 . . . . 0.0 110.478 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.5 m -119.27 156.82 29.27 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.8 mp -57.6 -45.93 84.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.9 -1.125 . . . . 0.0 109.371 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 75.3 m -62.19 -48.68 78.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 55' ' ' THR . 54.0 t0 -51.0 -32.32 20.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.19 -20.94 60.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.814 -1.179 . . . . 0.0 108.452 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 65.43 54.07 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 109.476 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.24 150.28 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.289 -0.882 . . . . 0.0 109.548 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -143.78 76.65 1.52 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.355 -0.841 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -97.56 -3.34 39.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 98.5 mt-10 50.72 45.71 26.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.547 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.405 ' OG ' ' O ' ' A' ' 64' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' TPO . 19.9 mt -93.78 117.09 29.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.946 . . . . 0.0 109.572 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -108.31 138.55 44.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.656 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mp -139.45 155.24 47.72 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.51 -0.744 . . . . 0.0 108.996 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.5 t -131.45 119.51 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.37 -0.831 . . . . 0.0 108.974 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.5 tt -83.99 143.07 30.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -111.97 151.54 29.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -0.779 . . . . 0.0 109.274 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' H ' HD11 ' A' ' 8' ' ' LEU . 50.8 mt -112.03 136.0 51.95 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.451 -0.781 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 48.4 mtm180 -99.99 140.96 33.46 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.309 -0.869 . . . . 0.0 109.249 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.17 1.74 90.14 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.335 0.588 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -82.12 104.42 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -79.51 137.01 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.53 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -95.65 155.96 16.53 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.346 -0.846 . . . . 0.0 109.62 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.2 t -141.5 113.94 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.335 -0.853 . . . . 0.0 108.743 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.66 118.52 36.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.228 -0.92 . . . . 0.0 109.855 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 m -92.13 153.89 19.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.293 -0.879 . . . . 0.0 109.021 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -55.71 -24.7 36.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.52 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.4 p -83.11 -2.71 56.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -0.953 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.4 -12.46 64.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -53.64 114.6 1.6 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.156 . . . . 0.0 109.109 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -92.95 136.61 33.1 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.217 -0.927 . . . . 0.0 109.69 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 13' ' ' ILE . 31.5 mt -142.24 137.68 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -128.16 142.26 51.23 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.235 -0.915 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -124.99 117.77 24.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.28 114.31 26.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.026 . . . . 0.0 109.543 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' OD2' ' A' ' 21' ' ' ASP . 5.4 p -161.92 153.78 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' VAL . 97.3 mt-10 -43.54 121.74 3.44 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.394 -0.816 . . . . 0.0 109.883 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 21' ' ' ASP . 87.3 Cg_exo -41.58 -24.96 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.062 1.841 . . . . 0.0 112.711 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 p -75.44 19.21 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.107 . . . . 0.0 109.687 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 19' ' ' PRO . 7.7 t70 -57.24 163.71 2.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 109.948 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -103.59 143.67 32.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.574 -0.703 . . . . 0.0 109.276 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -56.15 -52.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 109.988 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -46.7 -39.89 12.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 44.9 t30 -64.56 -42.16 95.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.72 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.6 t -61.01 -57.43 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -44.3 -29.33 0.64 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -65.44 -58.07 6.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.386 -0.822 . . . . 0.0 108.976 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 1.4 mptm? -53.45 -28.98 33.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -77.9 -66.04 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.816 -1.178 . . . . 0.0 108.763 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -43.78 -47.19 7.97 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.638 -0.664 . . . . 0.0 110.85 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 9.8 m-20 -71.56 -54.99 8.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 110.946 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 22.4 mmmt -58.4 -41.09 84.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.733 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -91.58 -24.14 19.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.762 -1.211 . . . . 0.0 109.611 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 70.23 16.38 73.17 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.1 mt -99.85 108.69 52.76 Favored Pre-proline 0 C--N 1.305 -1.327 0 O-C-N 121.575 -0.956 . . . . 0.0 109.809 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.29 121.48 5.4 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.859 1.706 . . . . 0.0 111.974 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -40.48 -35.69 1.51 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.417 2.078 . . . . 0.0 113.224 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.65 -42.44 34.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.43 -0.794 . . . . 0.0 110.258 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -84.81 5.29 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.235 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -130.25 143.32 50.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.508 -0.745 . . . . 0.0 110.788 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -132.87 131.21 40.7 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.29 142.37 27.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.604 -1.31 . . . . 0.0 110.597 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -124.91 130.67 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -149.48 112.38 4.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.243 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.32 29.37 18.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.428 -0.795 . . . . 0.0 110.495 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.56 4.97 90.26 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -126.1 148.47 49.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.419 -1.048 . . . . 0.0 109.03 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -98.63 164.79 12.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.978 -1.076 . . . . 0.0 109.358 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -102.03 113.94 27.62 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.218 -0.926 . . . . 0.0 109.203 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.788 ' H ' HH11 ' A' ' 54' ' ' ARG . 78.1 mm-40 -93.74 155.78 17.05 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 59.3 p30 -71.35 156.57 39.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.28 43.44 7.47 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.788 HH11 ' H ' ' A' ' 51' ' ' GLU . 28.7 ttp180 -161.56 151.52 16.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -1.142 . . . . 0.0 109.951 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 56' ' ' LEU . 90.3 m -117.12 168.42 10.3 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' N ' HG22 ' A' ' 55' ' ' THR . 10.0 mp -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.976 . . . . 0.0 108.965 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -61.06 -48.73 80.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.8 -30.98 47.3 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CE1' ' NE ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -73.83 -16.19 61.15 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.9 t30 69.19 61.83 0.31 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.634 -0.666 . . . . 0.0 109.738 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' CD1' ' H ' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -84.94 116.81 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.83 -38.02 13.23 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.125 -0.984 . . . . 0.0 110.33 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' C ' ' H ' ' A' ' 65' ' ' SEP . 63.6 mttp -69.69 -31.79 70.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.099 . . . . 0.0 110.221 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' H ' ' CD1' ' A' ' 61' ' ' ILE . 98.9 mt-10 43.26 19.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.419 -0.8 . . . . 0.0 110.125 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.66 ' H ' ' C ' ' A' ' 63' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.432 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.07 139.99 35.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.57 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.491 ' C ' HD12 ' A' ' 69' ' ' LEU . 32.2 p80 -125.78 133.43 52.04 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 68' ' ' HIS . 9.4 mp -115.95 127.6 55.09 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.22 121.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.372 -0.83 . . . . 0.0 109.551 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -80.15 151.12 29.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.169 -0.957 . . . . 0.0 109.525 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -138.11 148.53 45.07 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -113.0 141.92 46.28 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.283 -0.886 . . . . 0.0 109.092 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -71.96 -48.12 47.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.15 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.35 15.53 70.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.566 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.466 ' CG ' ' OG1' ' A' ' 14' ' ' THR . 48.3 tt0 -81.81 94.42 7.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -74.74 137.53 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.158 -0.964 . . . . 0.0 109.365 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.53 161.69 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.172 -0.955 . . . . 0.0 109.766 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -140.09 142.85 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -129.24 118.88 23.06 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -90.17 171.73 9.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.283 -0.886 . . . . 0.0 109.317 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.31 -33.62 76.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.872 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -78.81 -5.3 53.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.58 -14.34 65.51 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -48.5 112.72 0.63 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -1.191 . . . . 0.0 108.984 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -92.56 145.65 24.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.88 . . . . 0.0 110.085 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -142.31 138.21 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' CG ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -117.4 129.67 56.0 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.31 -0.869 . . . . 0.0 109.25 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.87 115.79 24.54 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -97.12 114.42 26.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 p -160.93 152.35 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 109.326 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' SER . 96.1 mt-10 -45.38 125.68 5.94 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.343 -0.848 . . . . 0.0 109.657 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -41.43 -23.46 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.987 1.792 . . . . 0.0 112.387 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' GLU . 10.8 p -75.88 10.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.231 -0.918 . . . . 0.0 109.63 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 14.8 t0 -52.58 163.66 0.42 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 108.564 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -97.41 167.1 11.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.076 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -78.48 -42.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.1 pt-20 -59.07 -28.59 66.61 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.461 -0.774 . . . . 0.0 108.994 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 21.9 t-20 -66.93 -47.31 72.09 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 27' ' ' LYS . 39.7 t -56.02 -63.62 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' VAL . 98.6 mttt -42.11 -32.46 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.797 -0.564 . . . . 0.0 109.922 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -68.74 -58.17 4.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -51.77 -30.4 22.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.967 . . . . 0.0 109.311 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 31' ' ' GLN . 1.4 mp -77.5 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 30' ' ' ILE . 62.6 tt0 -38.52 -47.47 1.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.722 -0.611 . . . . 0.0 110.522 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.68 -53.42 11.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.223 -0.923 . . . . 0.0 110.7 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.84 -40.34 92.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 111.715 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -96.56 -30.8 13.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.833 -1.167 . . . . 0.0 110.639 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.64 21.71 55.42 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.4 mt -104.69 104.77 47.54 Favored Pre-proline 0 N--CA 1.485 1.289 0 O-C-N 121.623 -0.928 . . . . 0.0 109.857 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.17 132.31 27.93 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.117 1.878 . . . . 0.0 112.052 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -36.69 -53.75 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.573 2.182 . . . . 0.0 113.005 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -47.34 -36.24 9.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.718 -0.614 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -83.4 13.27 4.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.047 -1.033 . . . . 0.0 110.813 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 6.6 pt20 -148.31 147.16 28.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.953 -1.092 . . . . 0.0 110.478 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -133.63 133.35 41.87 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.7 mp -89.9 143.85 26.43 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.806 -1.184 . . . . 0.0 110.138 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.6 mm -118.71 131.38 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -151.39 123.2 8.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.809 -1.182 . . . . 0.0 109.945 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.22 19.79 0.56 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 0.0 111.145 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.88 -2.75 72.96 Favored Glycine 0 N--CA 1.498 2.833 0 O-C-N 120.692 -1.255 . . . . 0.0 110.539 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -111.44 145.13 39.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -1.223 . . . . 0.0 108.004 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.22 123.87 36.8 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.704 -1.248 . . . . 0.0 108.844 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.95 147.22 53.51 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.273 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -128.56 156.93 42.55 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.696 -0.627 . . . . 0.0 109.872 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 56.7 p30 -58.34 156.21 10.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.452 -0.78 . . . . 0.0 109.616 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 54' ' ' ARG . . . 82.65 173.0 48.92 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 53' ' ' GLY . 7.2 tpt180 58.37 157.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -1.107 . . . . 0.0 109.721 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 66.4 p -121.28 168.21 11.88 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.88 -46.51 89.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.143 -0.973 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.7 p -63.87 -49.51 72.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.067 -1.021 . . . . 0.0 108.343 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 55' ' ' THR . 93.7 m-20 -52.01 -30.24 24.4 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.656 -0.652 . . . . 0.0 109.617 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -73.3 -21.28 60.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.756 -1.215 . . . . 0.0 108.319 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.41 53.62 4.19 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.53 -0.731 . . . . 0.0 109.888 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.61 119.4 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.874 . . . . 0.0 109.197 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -89.34 65.33 7.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -80.6 -30.32 36.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.452 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 52.18 56.14 8.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.549 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.434 ' C ' ' O ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -84.58 117.66 23.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -108.76 130.83 55.38 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 mp -123.76 149.59 45.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.493 -0.755 . . . . 0.0 108.967 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -133.03 113.41 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 tt -96.92 147.62 23.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 109.89 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -120.6 145.07 47.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 125.03 50.08 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.277 -0.889 . . . . 0.0 109.091 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.46 160.34 31.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.424 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.27 4.05 90.33 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 CA-C-O 117.929 -1.484 . . . . 0.0 109.536 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.94 95.54 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -88.96 135.38 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.294 -0.879 . . . . 0.0 109.695 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.6 150.58 22.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -142.39 108.79 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.317 -0.864 . . . . 0.0 109.071 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -94.85 125.01 39.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.163 -0.961 . . . . 0.0 109.645 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 11' ' ' LYS . 77.0 p -82.9 171.9 13.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 109.663 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -69.64 -35.32 75.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -78.59 1.33 23.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 109.529 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -19.05 50.61 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 7' ' ' THR . 54.3 mtpt -53.25 112.5 0.89 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.235 . . . . 0.0 108.629 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -92.48 153.45 19.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 0.0 109.942 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.08 149.15 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.4 p -118.31 137.35 53.13 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -128.22 115.56 18.54 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.56 111.31 22.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.959 -1.088 . . . . 0.0 109.587 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.03 152.22 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.308 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 23.3 mp0 -46.42 150.78 1.1 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 109.378 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.08 -14.89 32.18 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.275 1.983 . . . . 0.0 111.947 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 p -80.91 8.13 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -49.94 163.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.837 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 m -101.03 165.53 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.058 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 ' HZ3' ' A' ' 27' ' ' LYS . 90.2 mt -66.81 -47.26 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 0.0 109.153 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.8 pt-20 -67.21 -25.7 66.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.43 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.22 -41.27 86.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.145 -0.972 . . . . 0.0 108.429 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.39 -56.03 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HZ3' HG22 ' A' ' 23' ' ' ILE . 57.8 mttp -48.64 -45.75 38.98 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.631 -0.668 . . . . 0.0 109.442 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.8 -54.4 19.45 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 108.996 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -46.85 -40.74 14.46 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.907 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.42 -43.7 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.879 -1.138 . . . . 0.0 109.37 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' GLY . 12.4 tm0? -48.67 -49.54 37.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 64.5 t0 -65.69 -31.42 72.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.37 -0.831 . . . . 0.0 110.734 -179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -81.93 -44.06 17.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.849 -1.157 . . . . 0.0 110.926 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -93.6 -30.25 15.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.953 -1.092 . . . . 0.0 110.108 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 93.37 13.06 56.51 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 34.8 mt -95.42 112.64 59.5 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.632 -0.923 . . . . 0.0 109.418 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.97 156.73 0.44 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.725 1.617 . . . . 0.0 111.693 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.9 -29.64 8.2 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.666 2.244 . . . . 0.0 112.769 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.03 -19.82 61.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.712 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -93.71 6.49 48.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 44.2 mt-30 -127.95 136.1 50.86 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -131.96 127.3 36.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 mt -88.05 142.37 27.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.747 -1.221 . . . . 0.0 111.1 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.85 135.26 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -137.2 110.08 7.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.193 -0.942 . . . . 0.0 109.836 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 49.67 13.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.465 -0.772 . . . . 0.0 111.004 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.74 -1.55 15.26 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 120.828 -1.17 . . . . 0.0 110.945 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -89.78 167.42 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.746 -1.444 . . . . 0.0 109.876 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -130.01 125.12 34.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.675 -0.641 . . . . 0.0 109.4 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.91 124.83 36.31 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.276 -0.89 . . . . 0.0 109.661 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -94.35 139.66 30.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.309 -0.87 . . . . 0.0 109.395 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.99 156.27 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.879 . . . . 0.0 109.807 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.57 32.14 10.61 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -154.96 154.29 32.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -1.11 . . . . 0.0 110.386 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 57' ' ' SER . 2.1 m -114.57 154.52 28.16 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.23 -46.7 79.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.972 -1.08 . . . . 0.0 109.529 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 55' ' ' THR . 74.9 m -62.52 -50.12 72.64 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 55' ' ' THR . 26.2 t70 -47.72 -34.14 7.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.615 -0.678 . . . . 0.0 109.522 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.32 -21.19 59.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.025 -1.047 . . . . 0.0 108.861 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 57' ' ' SER . 12.9 m120 58.08 55.59 5.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.892 . . . . 0.0 109.201 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.5 mt -81.83 128.95 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.76 64.74 5.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.898 . . . . 0.0 109.198 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' NZ ' ' H ' ' A' ' 68' ' ' HIS . 19.9 tptm -71.25 -30.35 66.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 52.85 36.16 20.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 109.158 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.503 ' OG ' ' N ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.503 ' N ' ' OG ' ' A' ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.9 mt -90.09 117.65 29.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.411 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 98.9 m-70 -105.21 136.82 44.02 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 109.429 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.1 mt -137.08 150.48 48.05 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 108.948 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -127.26 115.84 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tt -82.82 138.85 33.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.097 . . . . 0.0 109.555 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -105.11 146.6 28.94 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.344 -0.848 . . . . 0.0 108.803 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -85.89 126.15 33.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.061 -1.024 . . . . 0.0 109.56 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 51.66 -117.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.416 -0.803 . . . . 0.0 109.673 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.82 -168.29 50.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.522 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ttt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -73.09 95.91 2.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.427 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 96.8 mt -99.92 131.44 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.199 -0.938 . . . . 0.0 109.752 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -88.3 158.57 18.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.16 104.96 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -99.33 124.67 44.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.246 -0.909 . . . . 0.0 110.001 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.8 p -91.5 159.55 15.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.972 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.2 mt -67.22 -20.55 65.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 p -81.77 -0.12 41.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.267 -0.896 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.51 -17.59 55.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -65.94 97.12 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -100.44 121.71 41.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.207 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.0 pt -108.04 156.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.26 -0.9 . . . . 0.0 109.146 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.3 p -97.87 122.64 41.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 0.0 109.361 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 ' HZ2' ' A' ' 33' ' ' LYS . 4.5 tp -122.15 114.3 20.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.496 -0.753 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.26 118.46 36.69 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -0.889 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.8 p -158.55 147.3 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 109.221 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -50.83 150.72 4.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.378 -0.826 . . . . 0.0 109.456 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.63 -22.9 15.2 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.494 2.13 . . . . 0.0 112.728 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 55' ' ' THR . 3.8 p -74.94 -10.1 59.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.738 -1.226 . . . . 0.0 109.708 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.86 151.02 4.84 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.537 ' H ' HD22 ' A' ' 25' ' ' ASN . 69.2 p -82.48 173.07 12.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.917 -1.114 . . . . 0.0 110.031 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 50' ' ' LEU . 96.0 mt -69.3 -50.33 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.447 -0.783 . . . . 0.0 109.546 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.57 -31.23 62.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.537 HD22 ' H ' ' A' ' 22' ' ' THR . 83.7 m-20 -64.64 -39.69 94.15 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.15 -59.54 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -46.35 -45.77 17.87 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.664 -0.648 . . . . 0.0 109.763 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.82 42.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.354 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -48.54 -38.56 20.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 109.452 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 34' ' ' GLU . 88.4 mt -75.95 -39.44 37.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.874 -1.141 . . . . 0.0 109.371 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' GLY . 14.8 tt0 -52.67 -49.3 65.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.322 -0.861 . . . . 0.0 109.808 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.48 -34.28 77.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.33 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HZ2' HD11 ' A' ' 15' ' ' LEU . 97.6 mttt -76.59 -44.13 35.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 111.058 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' OE1' ' CG2' ' A' ' 30' ' ' ILE . 50.2 mt-10 -95.87 -32.75 12.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.963 -1.085 . . . . 0.0 110.267 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 90.7 16.92 53.93 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.7 mt -92.59 136.18 25.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.485 -1.009 . . . . 0.0 109.419 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.18 121.38 6.1 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.817 1.678 . . . . 0.0 111.637 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -39.5 -31.97 0.42 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.856 2.371 . . . . 0.0 114.191 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.03 -19.23 65.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.846 -1.159 . . . . 0.0 110.669 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 74' ' ' ARG . 74.5 mm-40 -92.23 -2.56 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.963 -1.086 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -141.06 139.64 34.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -131.24 137.9 49.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 43' ' ' LEU . 7.4 mp -86.28 140.2 30.31 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.6 mm -123.94 136.57 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.306 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -136.82 110.84 8.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.113 -0.992 . . . . 0.0 109.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.42 50.46 12.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.454 -0.778 . . . . 0.0 110.824 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.82 15.83 Favored Glycine 0 N--CA 1.491 2.341 0 O-C-N 120.904 -1.123 . . . . 0.0 110.97 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -88.76 165.55 14.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.782 -1.422 . . . . 0.0 110.039 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.79 120.96 34.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.8 mp -95.2 130.34 41.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 109.232 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -93.94 156.43 16.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -57.37 153.26 12.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 54' ' ' ARG . . . 77.37 -179.89 49.99 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 6.9 tpt180 78.21 156.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -1.024 . . . . 0.0 109.319 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' SER . 24.3 m -119.45 157.49 28.15 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.626 -0.671 . . . . 0.0 109.562 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.17 -42.83 99.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.173 -0.955 . . . . 0.0 109.453 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.531 ' H ' HG22 ' A' ' 55' ' ' THR . 75.2 m -59.23 -50.35 74.34 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -50.02 -34.44 21.29 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.77 -16.81 61.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -0.968 . . . . 0.0 109.16 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 57.97 63.13 1.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -0.937 . . . . 0.0 109.773 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.98 134.25 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.151 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.12 -53.15 59.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.187 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 64' ' ' GLU . 68.6 mttm -64.64 -32.07 73.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.032 -1.042 . . . . 0.0 110.24 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' A' ' 65' ' ' SEP . 75.7 tt0 43.06 58.93 3.1 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.178 -0.951 . . . . 0.0 110.362 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.451 ' O ' ' C ' ' A' ' 66' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TPO . . . . . 0.452 ' N ' ' CE ' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -172.01 158.09 4.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 109.314 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' H ' HD23 ' A' ' 67' ' ' LEU . 71.0 m80 -110.6 152.46 26.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 mt -124.86 161.07 27.35 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 110.7 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.168 -0.957 . . . . 0.0 109.004 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.0 mp -82.99 147.62 28.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 109.664 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -105.31 144.75 31.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.354 -0.841 . . . . 0.0 108.866 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 74' ' ' ARG . 51.4 mt -81.23 125.65 30.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.474 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 40' ' ' GLN . 54.5 ttp180 57.37 162.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.434 -0.792 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.64 -173.93 44.5 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.601 179.974 . . . . . . . . 0 0 . 1 stop_ save_